<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq:Pyt (Mixed Bag-1) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 6708,
    "choices": [
      {
        "id": 26801,
        "text": "<p><span style=\"font-size:12.0pt;\">0.5 to 1 mEq/dL</span></p>"
      },
      {
        "id": 26802,
        "text": "<p><span style=\"font-size:12.0pt;\">0.1 to 0.5 mEq/dL</span></p>"
      },
      {
        "id": 26803,
        "text": "<p><span style=\"font-size:12.0pt;\">0.6 to 1.5 mEq/dL</span></p>"
      },
      {
        "id": 26804,
        "text": "<p><span style=\"font-size:12.0pt;\">2 to 3 mEq/dL</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the dose range of lithium in mEq/dL for acute attacks of mania and long-term maintenance?</span></p>",
    "unique_key": "Q3433808",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828656,
    "difficulty_level": "intermediate",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 0.6 to 1.5 mEq/dL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lithium has a narrow therapeutic window and its serum concentrations need careful monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">0.6 to 1.5 mEq/dL represents the general therapeutic range for lithium. According to 12th edition of Synopsis of Psychiatry,&nbsp; for acute manic episodes, the target serum lithium level is between 1.0 to 1.2 mEq/dL, while for long-term maintenance, it is 0.4 to 0.8 mEq/dL. The option closes to this range is option C.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 0.5 to 1 mEq/dL</strong> is close but not the typical therapeutic range. It is on the lower end and might not be effective for many patients, especially during acute mania.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 0.1 to 0.5 mEq/dL</strong> is subtherapeutic. Such low levels wouldn't be effective for the treatment of bipolar disorder and would not offer the necessary mood-stabilizing effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 2 to 3 mEq/dL</strong> is a toxic range. Lithium concentrations at this level can result in severe side effects and even life-threatening toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 655</strong></span></p>",
    "correct_choice_id": 26803,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 6771,
    "choices": [
      {
        "id": 27053,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inside the membrane</span></span></span></p>"
      },
      {
        "id": 27054,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At the C-terminal</span></span></span></p>"
      },
      {
        "id": 27055,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At the N-terminal</span></span></span></p>"
      },
      {
        "id": 27056,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Both inside the membrane and at C- terminal</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The signaling sequence in a type 2 membrane protein with N-terminal facing cytoplasm is located in?</span></span>(INICET May 2022)</p>",
    "unique_key": "Q4791685",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828432,
    "difficulty_level": "difficult",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Inside the membrane</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The signaling sequence in a type 2 membrane protein is located inside the membrane.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">These sequences usually have methionine as the terminal amino acid.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transmembrane proteins are integral proteins that span across the plasma/ endoplasmic reticulum (ER) membrane. They are classified into types 1 to 4. &ndash; </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Type 1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> membrane proteins have a cleavable N-terminal signal sequence outside the cell, a transmembrane sequence that is usually situated close to the C-terminus and the C-terminus facing inside the cell, e.g., low-density lipoprotein receptor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Type 2</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> membrane proteins have the N-terminal towards the cytosol and the C-terminal towards the exterior, e.g., transferrin receptor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Type 3</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> membrane proteins are identical to type 1 but have a shorter N terminal, e.g., cytochrome P450 enzyme complexes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 4</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> membrane proteins consist of 7 alpha helices traversing the membrane, e.g., glucose transporters and G-protein-coupled receptors.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/inicet-physio-may-2022-01.jpg\" style=\"height:262px; width:700px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. At the C-terminal</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is incorrect because the signaling sequence in type 2 membrane proteins is not located at the C-terminal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. At the N-terminal:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is incorrect as well. In type 2 membrane proteins, the N-terminal is facing the cytoplasm, but the signaling sequence itself is located inside the membrane.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Both inside the membrane and at C-terminal:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is incorrect because the signaling sequence is located specifically inside the membrane, not at the C-terminal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The signaling sequence in type 2 membrane proteins is located inside the membrane, crucial for the proper orientation and insertion of the protein.</span></span></p>",
    "correct_choice_id": 27053,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 23204,
    "choices": [
      {
        "id": 92780,
        "text": "<p><span style=\"font-size:12.0pt;\">1-D, 2-C, 3-A, 4-B</span></p>"
      },
      {
        "id": 92781,
        "text": "<p><span style=\"font-size:12.0pt;\">1-C, 2-A, 3-B, 4-D</span></p>"
      },
      {
        "id": 92782,
        "text": "<p><span style=\"font-size:12.0pt;\">1-A, 2-B, 3-C, 4-D</span></p>"
      },
      {
        "id": 92783,
        "text": "<p><span style=\"font-size:12.0pt;\">1-B, 2-A, 3-C, 4-D</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Match the following :&nbsp;</span>(INICET MAY 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/04/screenshot-2023-11-04-192316.png\" alt=\"\" width=\"700\" height=\"274\"></span></p>",
    "unique_key": "Q2188219",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828443,
    "difficulty_level": "beginner",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. 1-B, 2-A, 3-C, 4-D</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Facial nerve - B. Taste from anterior two-thirds of the tongue</strong>: The facial nerve (CN VII) is responsible for carrying taste sensations from the anterior two-thirds of the tongue. It also controls the muscles of facial expression.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Spinal accessory nerve - A. Shrugging of the shoulder:</strong> The spinal accessory nerve (CN XI) innervates the trapezius muscle, which is responsible for actions such as shrugging the shoulder and scapula elevation. It also contributes to head rotation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Glossopharyngeal nerve - C. Taste from the posterior one-third of the tongue</strong>: The glossopharyngeal nerve (CN IX) carries taste sensations from the posterior one-third of the tongue. It also plays a role in swallowing and provides sensory information from the throat and tonsils.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Mandibular nerve - D. Chewing:</strong> The mandibular nerve (V3) is a branch of the trigeminal nerve (CN V) and is responsible for innervating the muscles of mastication (chewing), as well as providing sensory input to the lower jaw, teeth, and gums.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/16/screenshot-2024-05-16-125921.JPG\" alt=\"\" width=\"700\" height=\"229\"></strong></span></p>",
    "correct_choice_id": 92783,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 54672,
    "choices": [
      {
        "id": 218153,
        "text": "<p><span style=\"font-size:12.0pt;\">Occurs more commonly in men</span></p>"
      },
      {
        "id": 218154,
        "text": "<p><span style=\"font-size:12.0pt;\">Is commonly associated with concomitant hypothyroidism</span></p>"
      },
      {
        "id": 218155,
        "text": "<p><span style=\"font-size:12.0pt;\">Characterised by at least four distinct episodes per year</span></p>"
      },
      {
        "id": 218156,
        "text": "<p><span style=\"font-size:12.0pt;\">Antidepressants increase the likelihood</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Rapid cycling in bipolar disorder is characterised by all of the following features except:&nbsp;(INICET MAY 2024)</span></p>",
    "unique_key": "Q3022150",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828653,
    "difficulty_level": "intermediate",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) Occurs more commonly in men</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Rapid cycling in bipolar disorder is defined by having four or more distinct mood episodes (mania, hypomania, or depression) within a single year.</span></li><li><span style=\"font-size:12.0pt;\">This condition is more commonly observed in females.</span></li><li><span style=\"font-size:12.0pt;\">Several factors, including hypothyroidism and substance abuse, can contribute to the likelihood of rapid cycling.</span></li><li><span style=\"font-size:12.0pt;\">Additionally, the use of antidepressants has been found to increase the risk of triggering rapid cycling episodes.</span></li><li><span style=\"font-size:12.0pt;\">Mood stabilizer of choice - Valproate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Is commonly associated with concomitant hypothyroidism:</strong> This statement is correct. Hypothyroidism is known to be associated with an increased risk of rapid cycling in bipolar disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Characterised by at least four distinct episodes per year:</strong> This statement is correct. The definition of rapid cycling specifically includes the occurrence of four or more mood episodes in one calendar year.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Antidepressants increase the likelihood:</strong> This statement is correct. The use of antidepressants can indeed increase the likelihood of rapid cycling in individuals with bipolar disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rapid cycling in bipolar disorder is more commonly seen in females and is characterized by at least four distinct episodes per year.</span></p>",
    "correct_choice_id": 218153,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 15115,
    "choices": [
      {
        "id": 60420,
        "text": "<p><span style=\"font-size:12.0pt;\">Superficial perineal pouch</span></p>"
      },
      {
        "id": 60421,
        "text": "<p><span style=\"font-size:12.0pt;\">Deep perineal pouch</span></p>"
      },
      {
        "id": 60422,
        "text": "<p><span style=\"font-size:12.0pt;\">Skin around penis</span></p>"
      },
      {
        "id": 60423,
        "text": "<p><span style=\"font-size:12.0pt;\">Skin around the scrotum</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The rupture of penile urethra does not cause extravasation of blood into which of the following spaces? (INICET MAY 2022)</span></p>",
    "unique_key": "Q7054889",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828446,
    "difficulty_level": "difficult",
    "subjects_id": [
      3
    ],
    "solution": "<p><strong>Ans. B. Deep perineal pouch</strong></p><p>&nbsp;</p><p><strong>Option B. Deep perineal pouch</strong>: This is a space situated superior to the perineal membrane and inferior to the pelvic diaphragm. It contains the membranous urethra, deep transverse perineal muscles, and parts of the external urethral sphincter. Extravasation of urine is possible in deep perineal pouch.</p><p>&nbsp;</p><p>When there is a rupture of the penile urethra (often due to trauma, such as a straddle injury), the extravasation of urine and blood can occur into various anatomical spaces, depending on the location and nature of the injury.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Superficial perineal pouch</strong>: This is a space located in the urogenital triangle of the perineum, bounded above by the perineal membrane and below by the perineal (Colles') fascia. The pouch contains the root of the penis (including the bulb of the penis) and the associated muscles. A rupture of the penile urethra can cause extravasation of urine and blood into this space.</p><p>&nbsp;</p><p><strong>Option C. Skin around penis</strong>. The skin around base of penis may get involved if the rupture is located in the bulbous part of urethra.</p><p>&nbsp;</p><p><strong>Option D. Skin around the scrotum</strong>: With a rupture of the penile urethra, especially if the rupture occurs in the bulbous part located within the superficial perineal pouch, the extravasated urine and blood can dissect through the fascial layers and present as swelling and bruising around the scrotum and base of the penis. This is often referred to as a \"butterfly\" pattern of bruising, as the extravasated fluid can spread anteriorly onto the anterior abdominal wall and laterally to the thighs but is typically limited superiorly by Scarpa's fascia.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Rupture of the penile urethra causes extravasation of blood into the superficial perineal pouch, scrotum, penis, and then up to the lower anterior abdominal wall.</p><p>&nbsp;</p><p>The membranous layer of superficial fascia attaches to the ischiopubic rami and forms the lateral borders of the urogenital triangle. Thus, the urine does not extravasate to the thigh.</p>",
    "correct_choice_id": 60421,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 34043,
    "choices": [
      {
        "id": 136007,
        "text": "<p><span style=\"font-size:12.0pt;\">Adipose</span></p>"
      },
      {
        "id": 136008,
        "text": "<p><span style=\"font-size:12.0pt;\">RBC</span></p>"
      },
      {
        "id": 136009,
        "text": "<p><span style=\"font-size:12.0pt;\">Pancreas</span></p>"
      },
      {
        "id": 136010,
        "text": "<p><span style=\"font-size:12.0pt;\">Brain</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Insulin independent absorption occurs in all except: (INICET NOV 2023)</span></p>",
    "unique_key": "Q6213718",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828429,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Adipose</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glucose uptake in adipose tissue is insulin-dependent, primarily using GLUT4 transporters activated by insulin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. RBC:</strong> Red Blood Cells utilize GLUT1 transporters for glucose absorption, which is insulin-independent and crucial for their energy needs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pancreas:</strong> While the pancreas plays a role in insulin production, its glucose absorption is not predominantly insulin-independent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Brain:</strong> The brain absorbs glucose independently of insulin, using GLUT3 transporters, essential for its constant energy requirements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glucose uptake in adipose tissue is insulin-dependent, while RBCs, pancreas, and brain utilize insulin-independent mechanisms for glucose absorption.</span></p>",
    "correct_choice_id": 136007,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 13718,
    "choices": [
      {
        "id": 54833,
        "text": "<p><span style=\"font-size:12.0pt;\">Atlanto-occipital</span></p>"
      },
      {
        "id": 54834,
        "text": "<p><span style=\"font-size:12.0pt;\">Atlanto-axial</span></p>"
      },
      {
        "id": 54835,
        "text": "<p><span style=\"font-size:12.0pt;\">C2-C3</span></p>"
      },
      {
        "id": 54836,
        "text": "<p><span style=\"font-size:12.0pt;\">C3-C4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which joint allows for the side-to-side movement of the head, enabling a person to look to the right and left?(NEET PG 2019)</span></p>",
    "unique_key": "Q2078011",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828551,
    "difficulty_level": "beginner",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Atlanto-axial</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The movements at the atlanto-axial joint allow a person to look left and right.</span></li><li><span style=\"font-size:12.0pt;\">The atlanto-axial joints consist of two lateral joints located on either side between the bottom of the atlas bone and the top of the axis bone, which are flat joints.</span></li><li><span style=\"font-size:12.0pt;\">Additionally, there is a central joint between the dens (a protrusion from the axis bone) and the front arch and transverse ligament of the atlas, which is a pivot joint.</span></li><li><span style=\"font-size:12.0pt;\">This central joint has two distinct synovial cavities - one in the front and one in the back.</span></li><li><span style=\"font-size:12.0pt;\">Rotatory movements occur at all three joints and revolve around a vertical axis.</span></li><li><span style=\"font-size:12.0pt;\">The dens acts as a pivot around which the atlas rotates (carrying the skull with it), allowing the head to rotate side to side.</span></li><li><span style=\"font-size:12.0pt;\">The alar ligaments restrict movement. Atlanto-axial rotation has a normal range of about 40\u00b0.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Atlanto-Axial joint</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-896.jpg\" alt=\"\" width=\"500\" height=\"316\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Atlanto-occipital joint</strong>: This joint is formed between the first cervical vertebra (the atlas or C1) and the occipital bone of the skull. It primarily permits the \"nodding\" motion of the head, as in signaling \"yes\". This joint allows for flexion and extension of the head, but not significant rotation. It's the joint that lets you tilt your head upward or downward.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C2-C3 joint</strong>: This joint is between the second and third cervical vertebrae. While it does allow for some degree of rotation, it does not provide the primary rotational movement to look right or left. The range of motion at this joint is less compared to the atlanto-axial joint, and it's more involved in flexion, extension, and some lateral bending.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C3-C4 joint</strong>: This joint is between the third and fourth cervical vertebrae. Like the C2-C3 joint, the C3-C4 joint also provides some degree of rotation but not the primary movement. Its main movements are flexion, extension, and lateral bending of the neck. The lower down the cervical spine you go, the less rotational capacity there typically is at each subsequent joint.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Atlanto-axial joint</strong> is formed between the first cervical vertebra (the atlas or C1) and the second cervical vertebra (the axis or C2). The dens or odontoid process, fits into the atlas, allowing for a pivot-like rotation. This is the joint responsible for allowing the rotation of the head from side to side, as in signaling \"no\" or looking right and left. It provides the majority of the rotational capability of the head.</span></p>",
    "correct_choice_id": 54834,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 16079,
    "choices": [
      {
        "id": 64276,
        "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,4,5&nbsp; &nbsp;</span></p>"
      },
      {
        "id": 64277,
        "text": "<p><span style=\"font-size:12.0pt;\">5,4,2,3,1</span></p>"
      },
      {
        "id": 64278,
        "text": "<p><span style=\"font-size:12.0pt;\">5,1,2,3,4</span></p>"
      },
      {
        "id": 64279,
        "text": "<p><span style=\"font-size:12.0pt;\">1,3,4,2,5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Arrange in sequence the structures involved in the direct pathway: (INICET NOV 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Striatum</span></p><p><span style=\"font-size:12.0pt;\">2. Globus pallidus</span></p><p><span style=\"font-size:12.0pt;\">3. Substantia nigra</span></p><p><span style=\"font-size:12.0pt;\">4. Thalamus</span></p><p><span style=\"font-size:12.0pt;\">5. Cortex</span><br>&nbsp;</p>",
    "unique_key": "Q5749473",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828445,
    "difficulty_level": "difficult",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. 5,1,2,3,4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The correct sequence is as follows:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>5. Cortex -</strong> provides the initial input to the basal ganglia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Striatum </strong>- receives input from the cortex and is the first structure in the basal ganglia circuitry.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Globus pallidus </strong>- receives inhibitory input from the striatum and projects to the thalamus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Substantia nigra -</strong> provides dopaminergic input to the striatum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Thalamus -</strong> receives excitatory input from the globus pallidus and projects back to the cortex to complete the loop.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The basal ganglia needs the input from the cortex in order to act. The first and last component of the pathway is always the cerebral cortex.&nbsp;</span></p><p><br><span style=\"font-size:12.0pt;\">The complete pathway is Cortex/ Thalamus/ brain stem to stratum, then to globus pallidus &amp; substantia nigra then to thalamus and then back to cortex.</span></p><p><br><span style=\"font-size:12.0pt;\">Hence out of the available options 5,1,2,3,4 is the best suitable.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/anatomy-nov-inicet-2022-01.jpg\" alt=\"\" width=\"600\" height=\"527\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The putamen is located laterally and the internal capsule is located medially to the pallidum. The striatum and subthalamic nuclei send fibres to it. It is the primary basal ganglia output to the thalamus and superior colliculus. Each cerebral peduncle of the midbrain located deep to the crus cerebri contains the substantia nigra. Dopamine levels in the substantia nigra and striata are reduced in Parkinson's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:11.0pt;\">The correct order of structures in the direct pathway of the basal ganglia starts with the cortex and follows through the striatum, globus pallidus, substantia nigra, and ends at the thalamus. This pathway is fundamental in processing motor signals, which is particularly relevant in understanding disorders like Parkinson\u2019s disease.</span></p>",
    "correct_choice_id": 64278,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 6961,
    "choices": [
      {
        "id": 27812,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5-HT antagonist </span></span></span></p>"
      },
      {
        "id": 27813,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5-HT agonist</span></span></span></p>"
      },
      {
        "id": 27814,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium Channel Blocker action</span></span></span></p>"
      },
      {
        "id": 27815,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nitric oxide mediated vasodilation</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly woman on treatment for migraine presents with chest pain. She has a previous history of ischemic heart disease. Which of the following mechanism of the prescribed drug for migraine might have caused this presentation? (INICET NOV 2020)</span></span></p>",
    "unique_key": "Q1802971",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828419,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. 5-HT agonist</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chest pain in an elderly woman with a history of ischemic heart disease, who is on treatment for migraine, could potentially be linked to the mechanism of action of her migraine medication. Among the options given 5-HT agonists can cause this adverse effect. Triptans and ergotamine are a group of drugs that are used in acute attacks of migraine. They act on 5HT1B/1D receptors as agonist and cause vasoconstriction of the blood vessels. Therefore, they should be avoided in patients with coronary artery disease as they can precipitate myocardial infarction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>5-HT Antagonist</strong>: Serotonin (5-HT) antagonists like cyproheptadine and methysergide etc are used for prophylaxis of migraine (not in treatment). These drugs are not commonly associated with causing chest pain or exacerbating ischemic heart disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Calcium Channel Blocker Action</strong>: While calcium channel blockers (CCBs) are used in migraine prophylaxis, they are generally heart-protective and used in the treatment of angina and hypertension due to their vasodilatory effects. It&#39;s unlikely that CCBs would cause chest pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nitric Oxide Mediated Vasodilation</strong>: Nitric oxide donors (like nitrates) are used in the treatment of angina due to their vasodilatory effects. They are not typically used in migraine treatment, and their vasodilatory action would be more likely to relieve, rather than cause, ischemic chest pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5-HT Agonist</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> includes medications like triptans (e.g., sumatriptan), which are commonly used in migraine treatment. Triptans are 5-HT1B/1D receptor agonists and can cause vasoconstriction of blood vessels. In patients with ischemic heart disease, this vasoconstriction can exacerbate angina (chest pain) or precipitate myocardial infarction, especially if the coronary arteries are already compromised.</span></span></span></p>",
    "correct_choice_id": 27813,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 7050,
    "choices": [
      {
        "id": 28168,
        "text": "<p><span style=\"font-size:12.0pt;\">Adequate safety profile needs to be established</span></p>"
      },
      {
        "id": 28169,
        "text": "<p><span style=\"font-size:12.0pt;\">Cost to benefit has to be considered</span></p>"
      },
      {
        "id": 28170,
        "text": "<p><span style=\"font-size:12.0pt;\">Fixed dose combination of drugs is preferred over single drugs</span></p>"
      },
      {
        "id": 28171,
        "text": "<p><span style=\"font-size:12.0pt;\">Disease prevalence is considered</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is false about the selection of essential drugs? (INICET MAY 2021)</span></p>",
    "unique_key": "Q8002091",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828418,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Fixed dose combination of drugs is preferred over single drugs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The WHO has defined Essential Medicines (Drugs) as \u201cthose that satisfy the priority healthcare needs of the population. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost effectiveness. Essential medicines are intended to be available within the context of functioning health systems at all times and in adequate amounts, in appropriate dosage forms, with assured quality and adequate information, and at a price the individual and the community can afford.\u201d</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is generally false. While fixed-dose combinations (FDCs) can be beneficial in certain scenarios (like in the treatment of HIV/AIDS or tuberculosis), they are not universally preferred over single-drug formulations. The preference for FDCs or single drugs depends on several factors, including the therapeutic context, the risk of drug-drug interactions, patient adherence, and the potential for resistance development. Mostly, single drugs are preferred due to their flexibility in dosing and the ability to adjust individual components based on patient needs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Adequate safety profile needs to be established</strong>: This is true. When selecting essential drugs, it's crucial that they have a well-established safety profile. Safety is a key consideration to ensure that the benefits of a drug outweigh its risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cost to benefit has to be considered</strong>: This is also true. In the selection of essential drugs, the cost-effectiveness of a drug is an important factor. The aim is to provide the most effective treatment at the lowest possible cost.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Disease prevalence is considered</strong>: This is true. When selecting essential drugs, the prevalence of diseases in a population is an important consideration. Drugs to treat common and life-threatening diseases are typically prioritized.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The selection of essential drugs prioritizes factors like safety, cost-effectiveness, and disease prevalence. Fixed-dose combinations are not universally preferred over single drugs, as the choice depends on specific therapeutic needs and other considerations.</span></p>",
    "correct_choice_id": 28170,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 8771,
    "choices": [
      {
        "id": 35051,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The &quot;ebb&quot; phase is associated with a decline in body temperature and oxygen consumption</span></span></span></p>"
      },
      {
        "id": 35052,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The &quot;flow&quot; phase occurs after resuscitation from a state of shock</span></span></span></p>"
      },
      {
        "id": 35053,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The &quot;ebb&quot; phase is aimed at reducing posttraumatic energy depletion</span></span></span></p>"
      },
      {
        "id": 35054,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The &quot;ebb&quot; phase leads to activation of the innate immune system and induction of the hepatic&nbsp;acute-phase response</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is false about Cuthbertson&#39;s metabolic ebb and flow responses to trauma?(NEET PG 2018)</span></span></p>",
    "unique_key": "Q3826829",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828436,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans. D.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>The &quot;ebb&quot; phase leads to activation of the innate immune system and induction of the hepatic&nbsp;acute-phase response</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The &quot;flow&quot; phase (not &quot;ebb&quot;) leads to activation of the innate immune system and induction of the hepatic acute-phase response.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cuthbertson&#39;s ebb and flow response to trauma:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A short ebb phase characterized by hypometabolism occurs immediately after the injury and is characterized by a decrease in metabolic rate, oxygen consumption, body temperature, and enzymatic activity. The ebb phase is followed by a longer hypermetabolic flow phase marked by an increased catabolism, with a high oxygen consumption and an elevated resting energy expenditure rate.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The &quot;flow&quot; phase occurs after resuscitation from a state of shock, which leads to an increased metabolic turnover, activation of the innate immune system and induction of the hepatic acute-phase response.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-095825.png\" style=\"height:622px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. The &quot;ebb&quot; phase is associated with a decline in body temperature and oxygen consumption</span></strong><span style=\"font-size:12.0pt\">: Correct, this describes the initial hypometabolic state following trauma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. The &quot;flow&quot; phase occurs after resuscitation from a state of shock</span></strong><span style=\"font-size:12.0pt\">: Correct, marking the transition to a hypermetabolic state.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. The &quot;ebb&quot; phase is aimed at reducing posttraumatic energy depletion</span></strong><span style=\"font-size:12.0pt\">: Correct, as it focuses on conserving energy immediately after trauma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The statement that the &quot;ebb&quot; phase leads to activation of the innate immune system and induction of the hepatic acute-phase response is false. These processes are characteristics of the &quot;flow&quot; phase, which occurs after the initial ebb phase and involves increased metabolic activity and systemic responses aimed at recovery and defense.</span></span></span></p>",
    "correct_choice_id": 35054,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 8840,
    "choices": [
      {
        "id": 35327,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C fibers are more sensitive to pressure than A fibers</span></span></span></p>"
      },
      {
        "id": 35328,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A fibers are more sensitive to hypoxia than B fibers</span></span></span></p>"
      },
      {
        "id": 35329,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A fibers are more susceptible to pressure changes than C fibers</span></span></span></p>"
      },
      {
        "id": 35330,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A fibers are more susceptible to hypoxia than C fibers</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A person after sleeping overnight with the arm under his head now experiences paresis but no numbness in the morning. Which of the following is the best explanation for it?</span></span>(NEET PG 2022)</p>",
    "unique_key": "Q7157031",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828440,
    "difficulty_level": "beginner",
    "subjects_id": [
      2
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. A fibers are more susceptible to pressure changes than C fibers </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Explanation </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the above scenario, the patient has developed paresis (partial paralysis) but the pain sensation is intact (no numbness) suggests A fibers involvement as they carry motor, touch, and pressure sensations are most sensitive to pressure changes/compression. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A fibers are myelinated nerve fibers responsible for transmitting signals related to touch, pressure, and proprioception (the sense of one&#39;s body position). C fibers, on the other hand, are unmyelinated and transmit slower pain signals. While both types of fibers can be affected by pressure, A fibers are more vulnerable to damage from sustained pressure than C fibers, which are more resistant to compression.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/697.jpg\" style=\"height:665px; width:740px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. C fibers are more sensitive to pressure than A fibers.</span></strong><span style=\"font-size:12.0pt\"> - Incorrect. C fibers are unmyelinated and relatively more resistant to pressure compared to myelinated A fibers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. A fibers are more sensitive to hypoxia than B fibers.</span></strong><span style=\"font-size:12.0pt\"> - Not relevant to the scenario, as the issue is related to mechanical pressure, not oxygen deprivation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. A fibers are more susceptible to hypoxia than C fibers.</span></strong><span style=\"font-size:12.0pt\"> - Also not relevant to the given scenario, focusing on hypoxia instead of the impact of mechanical pressure or compression.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Relative susceptibility - </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-124637.png\" style=\"height:273px; width:1000px\" /></p>",
    "correct_choice_id": 35329,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 83331,
    "choices": [
      {
        "id": 331924,
        "text": "<p><span style=\"font-size:12.0pt;\">Sternal end</span></p>"
      },
      {
        "id": 331925,
        "text": "<p><span style=\"font-size:12.0pt;\">Acromial end</span></p>"
      },
      {
        "id": 331926,
        "text": "<p><span style=\"font-size:12.0pt;\">Shaft</span></p>"
      },
      {
        "id": 331927,
        "text": "<p><span style=\"font-size:12.0pt;\">Tubercle</span></p>"
      }
    ],
    "text": "<p>The ossification center of the clavicle used to confirm bone age for legal consent to marriage is? (NEET PG 2017)</p>",
    "unique_key": "Q6783135",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828422,
    "difficulty_level": "intermediate",
    "subjects_id": [
      10
    ],
    "solution": "<p><strong>Answer: A. Sternal end</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>The sternal (medial) end of the clavicle is the ossification center used to confirm bone age for legal consent to marriage. This is a critical ossification center for age estimation in the late teens and early twenties. The secondary center at the medial end of the clavicle appears at around 18 years of age and fuses with the shaft by 21-22 years of age in males (slightly earlier in females).</p><p>&nbsp;</p><p>In the context of legal consent to marriage, which typically requires individuals to be at least 18 years for females and 21 years for males in many jurisdictions, the fusion status of the medial end of the clavicle provides valuable evidence for age determination.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option&nbsp;B. Acromial end (Incorrect)</strong> The acromial (lateral) end of the clavicle is not commonly used for age determination related to legal consent for marriage as it fuses earlier and doesn't provide relevant age information for the late teens to early twenties.</p><p>&nbsp;</p><p><strong>Option&nbsp;C. Shaft (Incorrect)</strong> The shaft (body) of the clavicle is the primary ossification center that appears very early (around 5-6 weeks of intrauterine life) and is the first bone to begin ossification. It doesn't provide useful information for age estimation in the context of marriage consent.</p><p>&nbsp;</p><p><strong>Option&nbsp;D. Tubercle (Incorrect)</strong> The tubercle of the clavicle doesn't have a separate ossification center that would be relevant for age determination in the context of legal consent for marriage.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The medial (sternal) end of the clavicle is a key marker for age estimation between 18-22 years, making it highly valuable for legal age determination in marriage consent cases.</span></p>",
    "correct_choice_id": 331924,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 8797,
    "choices": [
      {
        "id": 35155,
        "text": "<p><span style=\"font-size:12.0pt;\">Foreign body obstruction in the bronchus</span></p>"
      },
      {
        "id": 35156,
        "text": "<p><span style=\"font-size:12.0pt;\">Equal to dead space</span></p>"
      },
      {
        "id": 35157,
        "text": "<p><span style=\"font-size:12.0pt;\">When 02 and CO2 ratio is equal</span></p>"
      },
      {
        "id": 35158,
        "text": "<p><span style=\"font-size:12.0pt;\">The PO2 of alveolar air is 159 mmHg and PCO2 is 40 mmHg</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">V/Q = infinity holds true in which of the following conditions?&nbsp;</span><span style=\"font-size:11pt;\">(NEET PG 2020)</span></p>",
    "unique_key": "Q6135782",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828438,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Equal to dead space</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">VA/Q= infinity suggests that Q is 0 which implies that there is no exchange of 02 &amp; CO2, and no gaseous exchange occurs in dead space.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In quantitative terms, the ventilation-perfusion ratio is expressed as Va/Q. When Va (alveolar ventilation) is normal for a given alveolus and Q (blood flow) is also normal for the same alveolus, the ventilation-perfusion ratio (Va/Q) is also said to be normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This ratio explains the respiratory exchange when there is an imbalance between alveolar ventilation and alveolar blood flow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Foreign body obstruction in the bronchus</strong>: Incorrect, as this condition would lead to an area with no ventilation (blocked by the foreign body) potentially resulting in a low V/Q ratio in the affected area rather than an infinite V/Q ratio.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. When O2 and CO2 ratio is equal</strong>: Incorrect, as this does not directly relate to the ventilation-perfusion ratio concept. This option is more a reflection of gas exchange effectiveness rather than a description of V/Q mismatches.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. The PO2 of alveolar air is 159 mmHg and PCO2 is 40 mmHg</strong>: Incorrect, these values are typical for normal alveolar air and do not indicate a V/Q mismatch situation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">VA /Q ratio is infinite in the following scenarios -</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Ventilation is normal but there is no perfusion.</span></li><li><span style=\"font-size:12.0pt;\">No gaseous exchange through the respiratory membranes of corresponding alveoli.</span></li><li><span style=\"font-size:12.0pt;\">The alveolar air equilibrates the humidified inspired air.</span></li><li><span style=\"font-size:12.0pt;\">Partial pressures of the 02 and CO, are 149 mmHg &amp; 0 mm Hg respectively.</span></li></ol>",
    "correct_choice_id": 35156,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 6411,
    "choices": [
      {
        "id": 25613,
        "text": "<p><span style=\"font-size:12.0pt;\">Bran</span></p>"
      },
      {
        "id": 25614,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffPsyllium</span></p>"
      },
      {
        "id": 25615,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffSenna</span></p>"
      },
      {
        "id": 25616,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffMethylcellulose</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A colonoscopy on an 80-year-old patient revealed brownish pigmented lesions, as shown below. He admitted to using laxatives on a regular basis. Which of the following laxatives is most likely to be the source of this problem?</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/16/screenshot-2024-07-16-125141.png\" alt=\"\" width=\"300\" height=\"278\"></span></p>",
    "unique_key": "Q3632852",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828423,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Senna</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image shows the colonoscopy finding of melanosis coli.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The use of stimulant purgatives like Senna , Cascara Sagrada and Bisacodyl can lead to the development of melanosis coli. Also they should not be used for more than 10 days due to the risk of developing atonic colon.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bran:&nbsp;</strong>Bran is a bulk-forming laxative that increases stool bulk and promotes regular bowel movements. It does not cause melanosis coli.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Psyllium:&nbsp;</strong>Psyllium is another bulk-forming laxative that absorbs water into the stool, making it easier to pass. It does not lead to melanosis coli.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Methylcellulose:&nbsp;</strong>Methylcellulose is a bulk-forming fiber laxative that works by absorbing water and increasing stool bulk. It is not associated with melanosis coli.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic use of stimulant laxatives like Senna can lead to melanosis coli, characterized by brownish-black pigmentation of the colonic mucosa seen on colonoscopy.</span></p>",
    "correct_choice_id": 25615,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "OlderNEETPG"
    ]
  },
  {
    "id": 31805,
    "choices": [
      {
        "id": 127090,
        "text": "<p><span style=\"font-size:12pt;\">Tacrolimus</span></p>"
      },
      {
        "id": 127091,
        "text": "<p><span style=\"font-size:12pt;\">Nifedipine</span></p>"
      },
      {
        "id": 127092,
        "text": "<p><span style=\"font-size:12pt;\">Diltiazem</span></p>"
      },
      {
        "id": 127093,
        "text": "<p><span style=\"font-size:12pt;\">Verapamil</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following drugs is an inhibitor of ATP binding cassette efflux pumps? (INICET NOV 2023)</span></p>",
    "unique_key": "Q6250504",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828413,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Verapamil</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Verapamil is known to inhibit the activity of ATP-binding cassette (ABC) transporters, such as P-glycoprotein, which is one of the most well-studied drug efflux transporters. By inhibiting P-glycoprotein, verapamil can increase the intracellular concentration of various drugs, which is why it is sometimes used as a pharmacokinetic enhancer to improve drug absorption and decrease drug clearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Tacrolimus:</strong> Tacrolimus is an immunosuppressant drug used mainly after allogeneic organ transplant to reduce the activity of the patient's immune system and lower the risk of organ rejection. It is not an inhibitor of the ATP-binding cassette efflux transporters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Nifedipine:</strong> Nifedipine is a calcium channel blocker used primarily to treat hypertension and angina pectoris. It is not known to inhibit ABC efflux transporters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Diltiazem:</strong> Diltiazem, like verapamil, is a calcium channel blocker, but it is not as potent as verapamil in inhibiting P-glycoprotein. However, it does have some effect on drug efflux transporters, but to a lesser extent compared to verapamil.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Verapamil is a known inhibitor of ATP-binding cassette transporters, particularly P-glycoprotein, and can be used to enhance the pharmacokinetics of various drugs by increasing their intracellular concentrations.</span></p>",
    "correct_choice_id": 127093,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 54787,
    "choices": [
      {
        "id": 218613,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1 only</span></span></span></p>"
      },
      {
        "id": 218614,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2 only</span></span></span></p>"
      },
      {
        "id": 218615,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1 and 2</span></span></span></p>"
      },
      {
        "id": 218616,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2, 3, and 4</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythropoietin is produced by: (INICET MAY 2024)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Kidney</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liver</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spleen</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lung&nbsp;</span></span></span></li>\r\n</ol>",
    "unique_key": "Q4407907",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828428,
    "difficulty_level": "beginner",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) 1 and 2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythropoietin is a hormone primarily produced by the kidneys and to a lesser extent by the liver. In a healthy individual, the majority of erythropoietin (approximately 90%) is produced by the kidney, specifically by peritubular interstitial fibroblasts. These cells respond to hypoxia (low oxygen levels) by increasing the production of erythropoietin, which then stimulates the bone marrow to produce more red blood cells. The liver also contributes to erythropoietin production, particularly through sinusoidal cells, although it accounts for only about 10% of the hormone&#39;s production under normal conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In certain pathological conditions, such as in some types of anemia (e.g., thalassemia major), the spleen may take on a role in erythropoietin production to compensate for the body&#39;s increased need for red blood cells. However, this is not the case in healthy individuals, which is why the spleen and other organs like the lung are not considered significant sources of erythropoietin under normal physiological conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3 and 4</span></strong><span style=\"font-size:12.0pt\">: While the spleen can contribute in pathological states, it is not a primary source under normal conditions, and the lung does not contribute to erythropoietin production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythropoietin is primarily produced by the kidneys, with the liver contributing to a lesser extent. Understanding the primary and secondary sources of erythropoietin is crucial, particularly in the context of conditions affecting red blood cell production.</span></span></span></p>",
    "correct_choice_id": 218615,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 44018,
    "choices": [
      {
        "id": 175731,
        "text": "<p><span style=\"font-size:12pt;\">Arrythmia</span></p>"
      },
      {
        "id": 175732,
        "text": "<p><span style=\"font-size:12pt;\">Confusion</span></p>"
      },
      {
        "id": 175733,
        "text": "<p><span style=\"font-size:12pt;\">Hypothermia</span></p>"
      },
      {
        "id": 175734,
        "text": "<p><span style=\"font-size:12pt;\">Pupillary dilatation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient was started on Amitryptiline and he was found to be unconscious. Which of the following doesn\u2019t suggest TCA toxicity ?</span>(INICET NOV 2023)</p>",
    "unique_key": "Q2906224",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828654,
    "difficulty_level": "beginner",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Hypothermia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">TCA toxicity typically presents with hyperthermia due to anticholinergic effects, not hypothermia.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-165526.JPG\" alt=\"\" width=\"1000\" height=\"445\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Arrhythmias: </strong>Arrhythmias are a hallmark of TCA toxicity, reflecting its impact on cardiac conductivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Confusion:&nbsp;</strong>Confusion or altered sensorium is common due to the central nervous system effects of TCAs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Pupillary dilatation:</strong> Pupillary dilatation results from the anticholinergic properties of TCAs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of TCA toxicity, we see symptoms like arrhythmias, confusion, and pupillary dilatation due to its anticholinergic and cardiotoxic properties. Hypothermia is not typically associated with TCA overdose.</span></p>",
    "correct_choice_id": 175733,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 24392,
    "choices": [
      {
        "id": 97529,
        "text": "<p><span style=\"font-size:12.0pt;\">Cotard's syndrome</span></p>"
      },
      {
        "id": 97530,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypochondriacal delusion</span></p>"
      },
      {
        "id": 97531,
        "text": "<p><span style=\"font-size:12.0pt;\">Nihilistic delusion</span></p>"
      },
      {
        "id": 97532,
        "text": "<p><span style=\"font-size:12.0pt;\">Bizarre delusion</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In this case, a young boy is exhibiting symptoms of reduced mood, decreased energy, and diminished engagement with his environment. He has refrained from eating for the past week and his thoughts include phrases like \"I have lost my mind. I am deceased. How can I consume food?\". What is the specific delusion in this scenario?&nbsp;</span>(INICET MAY 2023)</p>",
    "unique_key": "Q8156509",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828655,
    "difficulty_level": "beginner",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Nihilistic delusion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nihilistic delusion (delusion of negation, Cotard syndrome): Patients may deny the existence of their body, their mind, or the world in general. For example, a patient with severe depression claimed that all his internal organs have rotted.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Here, the best answer is Nihilistic delusion rather than Cotard syndrome because the question has specifically asked the type of delusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Hypochondriacal delusion: </strong>Hypochondriacal delusion&nbsp;is an illness anxiety disorder. It is characterized by a preoccupation with having or acquiring a serious physical illness. The preoccupation persists despite normal investigations and medical reassurances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;Bizarre delusion</strong>:</span> <span style=\"font-size:12.0pt;\">Scientifically impossible and culturally implausible (un-understandable). For example, a patient claimed that aliens stole his heart and lungs, and now he is living without those organs.</span></p>",
    "correct_choice_id": 97531,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET"
    ]
  },
  {
    "id": 8830,
    "choices": [
      {
        "id": 35287,
        "text": "<p><span style=\"font-size:12.0pt;\">280 mEq</span></p>"
      },
      {
        "id": 35288,
        "text": "<p><span style=\"font-size:12.0pt;\">480 mEq</span></p>"
      },
      {
        "id": 35289,
        "text": "<p><span style=\"font-size:12.0pt;\">840 mEq</span></p>"
      },
      {
        "id": 35290,
        "text": "<p><span style=\"font-size:12.0pt;\">1400 mEq</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man weighing 70 kg had a sodium level of 120 mEq, calculate sodium deficit? (NEET PG 2021)</span></p>",
    "unique_key": "Q3091081",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828439,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. 840 mEq</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The sodium deficit in the given scenario is 840 mEq.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Formula for calculating sodium deficit = 0.6 \u00d7 body weight x (target plasma sodium concentration - starting plasma sodium concentration).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Substituting values as per the question,</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sodium deficit = 0.6 x 70 \u00d7 (140 - 120) = 840 mEq.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Correcting sodium levels must be done cautiously, especially in cases of hyponatremia, to prevent complications like osmotic demyelination syndrome. Rapid changes in serum sodium can be dangerous, and adjustments should generally be made slowly, according to specific clinical guidelines.</span></p>",
    "correct_choice_id": 35289,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 55873,
    "choices": [
      {
        "id": 222925,
        "text": "<p><span style=\"font-size:12.0pt;\">Syndesmosis</span></p>"
      },
      {
        "id": 222926,
        "text": "<p><span style=\"font-size:12.0pt;\">Synchondrosis</span></p>"
      },
      {
        "id": 222927,
        "text": "<p><span style=\"font-size:12.0pt;\">Plane joint</span></p>"
      },
      {
        "id": 222928,
        "text": "<p><span style=\"font-size:12.0pt;\">Symphysis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which joint is not formed by the bone shown in the image? (INICET MAY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-171341.jpeg\" alt=\"\" width=\"300\" height=\"299\"></span></p>",
    "unique_key": "Q4503993",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828442,
    "difficulty_level": "difficult",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Synchondrosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image shows a thoracic vertebra, identifiable by its long spinous process, body, and superior and inferior articular facets. Thoracic vertebrae participate in forming several types of joints but do not form synchondroses. A synchondrosis is a primary cartilaginous joint where bones are joined by hyaline cartilage, which is not present in the thoracic vertebra.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-171354.jpeg\" alt=\"\" width=\"700\" height=\"535\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Syndesmosis:</strong> Incorrect. Syndesmosis joints are formed where two bones are connected by a ligament. An example related to the vertebrae would be the interspinous ligament connecting adjacent spinous processes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Plane joint:</strong> Incorrect. Plane joints are formed by thoracic vertebrae, such as the costovertebral and costotransverse joints, where the ribs articulate with the thoracic vertebrae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Symphysis:</strong> Incorrect. Symphysis joints are formed between the vertebral bodies of adjacent thoracic vertebrae via the intervertebral discs, which are composed of fibrocartilage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thoracic vertebrae do not form synchondrosis (primary cartilaginous) joints; they are involved in forming plane joints, syndesmosis, and symphysis joints.</span></p>",
    "correct_choice_id": 222926,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 44786,
    "choices": [
      {
        "id": 178791,
        "text": "<p><span style=\"font-size:12pt;\">Dapagliflozin</span></p>"
      },
      {
        "id": 178792,
        "text": "<p><span style=\"font-size:12pt;\">Pioglitazone</span></p>"
      },
      {
        "id": 178793,
        "text": "<p><span style=\"font-size:12pt;\">Sitagliptin</span></p>"
      },
      {
        "id": 178794,
        "text": "<p><span style=\"font-size:12pt;\">Metformin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anti-diabetic drug is associated with increased risk of urinary tract infections? (</span>INICET May 2024)</p>",
    "unique_key": "Q4462466",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828425,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Dapagliflozin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Dapagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor. SGLT2 inhibitors work by promoting the excretion of glucose through the urine. This increased urinary glucose can create an environment that promotes the growth of bacteria, thereby increasing the risk of urinary tract infections. This class of drugs is well known for its association with UTIs and genital infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Pioglitazone</strong>:&nbsp;Pioglitazone is a thiazolidinedione that improves insulin sensitivity. It is not associated with an increased risk of urinary tract infections. Common side effects include weight gain, edema, and an increased risk of heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Sitagliptin</strong>:&nbsp;Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing incretin levels, which in turn increase insulin secretion and decrease glucagon secretion. Sitagliptin is not commonly associated with an increased risk of urinary tract infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Metformin</strong>:&nbsp;Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity. It is not associated with an increased risk of urinary tract infections. Common side effects of metformin include gastrointestinal disturbances such as diarrhea and abdominal discomfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, dapagliflozin, an SGLT2 inhibitor, is associated with an increased risk of urinary tract infections due to its mechanism of increasing glucose excretion in the urine. This patient\u2019s recurrent UTIs could be related to her use of dapagliflozin.</span></p>",
    "correct_choice_id": 178791,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 48796,
    "choices": [
      {
        "id": 194767,
        "text": "<p><span style=\"font-size:12.0pt;\">Known as Sixth Disease</span></p>"
      },
      {
        "id": 194768,
        "text": "<p><span style=\"font-size:12.0pt;\">Known as Roseola</span></p>"
      },
      {
        "id": 194769,
        "text": "<p><span style=\"font-size:12.0pt;\">Caused by Herpes Virus</span></p>"
      },
      {
        "id": 194770,
        "text": "<p><span style=\"font-size:12.0pt;\">Associated with Slapped Cheek Appearance</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about exanthema subitum is incorrect? (NEET PG 2015)</span></p>",
    "unique_key": "Q8461592",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828420,
    "difficulty_level": "beginner",
    "subjects_id": [
      18
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Associated with Slapped Cheek Appearance</strong></span></p><p>&nbsp;</p><p><strong>Explanation</strong>:</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Exanthema subitum, also called <strong>Sixth Disease or Roseola infantum,</strong> is caused by <strong>Human Herpes Virus-6 (HHV-6).&nbsp;</strong></span></li><li><span style=\"font-size:12.0pt;\">The disease is characterized by abrupt onset of <strong>high-grade fever</strong>, followed by appearance of the <strong>rash after the fever subsides.&nbsp;</strong></span></li><li><span style=\"font-size:12.0pt;\">The rash resembles measles but is not described as having a \"slapped cheek appearance.\" <strong>Nagayama spots&nbsp;</strong>are associated with this condition, but not a slapped cheek appearance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Known as Sixth Disease - This is correct.&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Exanthema subitum is indeed known as the Sixth Disease in the classification of childhood exanthems.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Known as Roseola - This is correct.&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>HHV-6</strong> causes<strong> \"roseola infantum\"&nbsp;</strong>where \"roseola\" means rose-like and \"infantum\" refers to its common occurrence in infants.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Caused by Herpes Virus - This is correct.&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Exanthema subitum is caused by <strong>Human Herpes Virus-6 (HHV-6)</strong>, which is a member of the herpesvirus family.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Associated with Slapped Cheek Appearance - This is incorrect.&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The \"slapped cheek appearance\" is characteristic of <strong>Erythema Infectiosum (Fifth Disease)&nbsp;</strong>caused by <strong>Parvovirus B19</strong>, not exanthema subitum.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture1_MVVfDe3.png\" width=\"791\" height=\"464\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Parvovirus B19 infection causes a <strong>maculopapular rash</strong> that evolves into a <strong>reticulated lacy exanthem</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture2_Ju2Y05w.png\" width=\"682\" height=\"241\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Exanthema subitum (Sixth Disease/Roseola infantum)</strong> is caused by <strong>HHV-6</strong>, characterized by abrupt high fever followed by a<strong> rash after fever subsides</strong>, while the <strong>\"slapped cheek&nbsp;</strong>appearance\" is characteristic of <strong>Erythema Infectiosum (Fifth Disease)</strong> caused by <strong>Parvovirus B19.</strong></span></li></ul>",
    "correct_choice_id": 194770,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 13885,
    "choices": [
      {
        "id": 55501,
        "text": "<p><span style=\"font-size:12.0pt;\">Abductor pollicis longus</span></p>"
      },
      {
        "id": 55502,
        "text": "<p><span style=\"font-size:12.0pt;\">Palmar interossei</span></p>"
      },
      {
        "id": 55503,
        "text": "<p><span style=\"font-size:12.0pt;\">Opponens pollicis</span></p>"
      },
      {
        "id": 55504,
        "text": "<p><span style=\"font-size:12.0pt;\">Flexor pollicis brevis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following muscles is attached to the area marked green in the image below? (INICET NOV 2020)</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-87.jpg\" alt=\"\" width=\"200\" height=\"373\"></span></p>",
    "unique_key": "Q6610512",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828449,
    "difficulty_level": "intermediate",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Opponens pollicis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The palmar aspect of the first metacarpal is the area marked in the image. At this location, the opponens pollicis muscle inserts.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Opponens pollicis:</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Origin:</strong> Crest of the trapezium and flexor retinaculum</span></li><li><span style=\"font-size:12.0pt;\"><strong>Insertion:</strong> Whole length of the lateral border and adjoining lateral half of the palmar aspect of the first metacarpal.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Action:</strong> Flexes the metacarpal bone of the thumb.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image below shows various intrinsic muscles of the hand.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-88.jpg\" alt=\"\" width=\"600\" height=\"403\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Abductor Pollicis Longus: </strong>Abductor pollicis longus is not directly attached to the first metacarpal. It originates from the posterior surface of the ulna and radius and inserts into the base of the first metacarpal bone. Its primary action is to abduct the thumb away from the palm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Palmar Interossei: </strong>The palmar interossei muscles are located between the metacarpal bones in the palm of the hand. They are responsible for adducting the fingers toward the midline of the hand. They are not directly attached to the first metacarpal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Flexor Pollicis Brevis: </strong>The flexor pollicis brevis muscle has two heads: the superficial head and the deep head. The superficial head originates from the flexor retinaculum, while the deep head originates from the trapezoid and capitate bones.</span></p><ul><li><span style=\"font-size:12.0pt;\">Both heads of the flexor pollicis brevis insert into the base of the first metacarpal bone.</span></li><li><span style=\"font-size:12.0pt;\">The main action of the flexor pollicis brevis is to flex the thumb at the metacarpophalangeal joint.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The opponens pollicis muscle originates from the flexor retinaculum and the Crest of the trapezium bone. It inserts into the first metacarpal bone.</span></li><li><span style=\"font-size:12.0pt;\">The primary action of the opponens pollicis is to oppose the thumb, allowing for the grasping and pinching movements of the thumb.</span></li></ul>",
    "correct_choice_id": 55503,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 5511,
    "choices": [
      {
        "id": 22016,
        "text": "<p><span style=\"font-size:12.0pt;\">Repeated administration of ephedrine decreases its effect on blood pressure</span></p>"
      },
      {
        "id": 22017,
        "text": "<p><span style=\"font-size:12.0pt;\">High dose of acetylcholine after pretreatment with atropine produces increase in blood pressure and heart rate</span></p>"
      },
      {
        "id": 22018,
        "text": "<p><span style=\"font-size:12.0pt;\">A patient pre-treated with phentolamine develops severe hypotension on administration of adrenaline</span></p>"
      },
      {
        "id": 22019,
        "text": "<p><span style=\"font-size:12.0pt;\">Increase in blood pressure is produced by intravenous propranolol</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following correctly describes the phenomenon of vasomotor reversal of Dale? (Fmge Jan 2023)</span></p>",
    "unique_key": "Q3644551",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828414,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C. A patient pre-treated with phentolamine develops severe hypotension on administration of adrenaline</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Vasomotor Reversal of Dale:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Adrenaline stimulates both \u03b11 and \u03b22 receptors. The \u03b11 receptors have very strong vasoconstrictor property whereas the \u03b22 receptors are very sensitive receptors and they cause vasodilation. Since the \u03b11 receptors are stronger, on administration of adrenaline, they are stimulated leading to vasoconstriction. After some time, metabolism takes place and only \u03b22 is stimulated which causes low blood pressure. This phase does not also last for a long time as metabolism happens and brings back the blood pressure to the normal level. This is the biphasic response of adrenaline (two phases in which BP increases in the first phase and decreases in the second).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Phentolamine is a non-selective alpha blocker. So if adrenaline is administered along with it , then the alpha receptor stimulation will not happen , and there will be only stimulation of the \u03b22 receptors leading to vasodilation and severe hypotension. This phenomenon of a patient pretreated with phentolamine developing severe hypotension on the administration of adrenaline is known as the vasomotor reversal of Dale.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture40.jpg\" alt=\"\" width=\"500\" height=\"266\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. Repeated administration of ephedrine decreases its effect on blood pressure:</strong> This describes tachyphylaxis, which is a rapid decrease in response to a drug after repeated doses, not vasomotor reversal of Dale.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. High dose of acetylcholine after pretreatment with atropine produces an increase in blood pressure and heart rate:</strong> This describes the pharmacological effects of acetylcholine and atropine but is unrelated to vasomotor reversal of Dale.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Increase in blood pressure is produced by intravenous propranolol:</strong> Propranolol is a non-selective beta blocker that usually causes a decrease in blood pressure by blocking \u03b21 and \u03b22 receptors, leading to reduced cardiac output and vasodilation. This statement is incorrect and unrelated to vasomotor reversal of Dale.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The phenomenon of vasomotor reversal of Dale occurs when a patient pre-treated with an alpha blocker like phentolamine experiences severe hypotension upon administration of adrenaline due to the unopposed stimulation of \u03b22 receptors, leading to vasodilation instead of the usual vasoconstriction and pressor effect.</span></p>",
    "correct_choice_id": 22018,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 54757,
    "choices": [
      {
        "id": 218493,
        "text": "<p><span style=\"font-size:18px;\">Hemophilus influenzae B</span></p>"
      },
      {
        "id": 218494,
        "text": "<p><span style=\"font-size:18px;\">Pneumococcal vaccine</span></p>"
      },
      {
        "id": 218495,
        "text": "<p><span style=\"font-size:18px;\">Hepatitis B</span></p>"
      },
      {
        "id": 218496,
        "text": "<p><span style=\"font-size:18px;\">Meningococcal vaccine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>All of the following are types of polysaccharide vaccines except:&nbsp;[</strong><i><strong>INICET MAY 2024]</strong></i></span></p>",
    "unique_key": "Q5501523",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828658,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Hepatitis B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Hepatitis B is not a polysaccharide vaccine. It is a recombinant type of subunit vaccine, which means it is made using genetic engineering techniques to produce the surface antigens of the Hepatitis B virus</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Polysaccharide vaccines are designed to elicit an immune response specifically against the polysaccharides found on the surface of certain bacterial capsules. These vaccines include:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Haemophilus influenzae B (Hib) vaccine</strong>: Targets the polysaccharides on the surface of Haemophilus influenzae type B.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Pneumococcal vaccine</strong>: Targets the polysaccharides on the surface of Streptococcus pneumoniae.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Meningococcal vaccine</strong>: Targets the polysaccharides on the surface of Neisseria meningitidis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">These vaccines may also be available as glycoconjugate vaccines, which are designed to improve immunogenicity, especially in younger populations. However, the vaccine for <strong>Salmonella Typhimurium</strong> (Typhim VI) is available only in a polysaccharide form.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Hepatitis B is a recombinant subunit vaccine, not a polysaccharide vaccine.</strong> Polysaccharide vaccines include those for pneumococcus, meningococcus, and Haemophilus influenzae type B.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Note</strong> - Polysaccharide vaccines work by stimulating the immune system to produce antibodies specifically against the polysaccharide components of the bacterial capsule. These polysaccharides are unique to particular strains or serotypes of bacteria, making the vaccine effective in targeting those specific types.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Limitations of Polysaccharide vaccines</strong>: serotype-specific and do not facilitate herd immunity due to their lack of a robust T-cell response.&nbsp;&nbsp;</span></p>",
    "correct_choice_id": 218495,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 6759,
    "choices": [
      {
        "id": 27005,
        "text": "<p><span style=\"font-size:12.0pt;\">Tubuloglomerular feedback</span></p>"
      },
      {
        "id": 27006,
        "text": "<p><span style=\"font-size:12.0pt;\">Myogenic reflex</span></p>"
      },
      {
        "id": 27007,
        "text": "<p><span style=\"font-size:12.0pt;\">Renin-angiotensin system</span></p>"
      },
      {
        "id": 27008,
        "text": "<p><span style=\"font-size:12.0pt;\">Renal sympathetic system fires</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is NOT involved in renal auto-regulation?(INICET MAY 2021)</span></p>",
    "unique_key": "Q2171265",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828434,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><strong>Ans. D) Renal sympathetic system fires</strong></p><p>&nbsp;</p><p>Renal autoregulation is important to maintain the glomerular filtration rate (GFR). Blood flow to kidneys remains normal even when the mean arterial blood pressure very widely between 60 mm Hg and 180 mm Hg. This helps to maintain normal GFR.<br><br>The sympathetic nervous system can also influence renal blood flow, but its role is primarily to modulate GFR in response to systemic conditions rather than as part of the intrinsic autoregulatory mechanisms.&nbsp;Therefore, renal sympathetic system firing is not considered a key component of renal autoregulation.</p><p>&nbsp;</p><p>Two mechanisms are involved in renal autoregulation:</p><p>&nbsp;</p><ol><li>Myogenic response - mechanism that contributes to the maintenance of a relatively constant renal blood flow and GFR</li><li>Tubuloglomerular feedback via macula densa. Renin-angiotensin system also plays a role.</li></ol><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/inicet-physio-may-2021-02_XE4os0h.jpg\" alt=\"\" width=\"1006\" height=\"1189\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p>Macula densa feedback mechanism for autoregulation of glomerular hydrostatic pressure and glomerular filtration rate (GFR) during decreased renal arterial pressure.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Tubuloglomerular feedback:</strong>&nbsp;Incorrect. Tubuloglomerular feedback is a key component of renal autoregulation.</p><p>&nbsp;</p><p><strong>Option B. Myogenic reflex:</strong>&nbsp;Incorrect. The myogenic reflex is a crucial mechanism in renal autoregulation.The myogenic reflex helps regulate GFR by directly responding to changes in blood pressure (BP) within the afferent arteriole, which supplies blood to the glomerulus. When BP &nbsp;increases, the afferent arteriole smooth muscle stretches, triggering a contraction (vasoconstriction) that reduces blood flow into the glomerulus, thus decreasing GFR.</p><p>&nbsp;</p><p><strong>Option C. Renin-angiotensin system:</strong>&nbsp;Incorrect. The renin-angiotensin system supports renal autoregulation, particularly in adjusting the efferent arteriolar resistance.</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Renal autoregulation primarily involves the myogenic response and tubuloglomerular feedback mechanisms to maintain stable GFR. The renal sympathetic system, while involved in renal blood flow regulation, is not part of intrinsic autoregulation mechanisms.</span></p>",
    "correct_choice_id": 27008,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 16048,
    "choices": [
      {
        "id": 64152,
        "text": "<p>1</p>"
      },
      {
        "id": 64153,
        "text": "<p>2</p>"
      },
      {
        "id": 64154,
        "text": "<p>3</p>"
      },
      {
        "id": 64155,
        "text": "<p>4</p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient after a road traffic accident presents to the emergency room with difficulty in swallowing and slurred speech. Investigations reveal fractures in the occipitotemporal region. Which of the following areas should be tested in order to find the nerve which is involved? (</span>INICET Nov 2021)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/screenshot-2023-11-09-170026.png\" alt=\"\" width=\"400\" height=\"221\"></span></p>",
    "unique_key": "Q7110245",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828447,
    "difficulty_level": "intermediate",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The occipitotemporal fracture in the clinical scenario is suggestive of involvement of the 9th and 10th cranial nerves, which are tested by pressing on the uvula, which is indicated as 2 in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The jugular foramen is located between the lower border of the petrous part of the temporal bone and the condylar part of the occipital bone. As the investigations reveal fractures in the occipitotemporal region, along with the history of difficulty in swallowing and slurred speech, are suggestive of injury to the glossopharyngeal and vagus nerve passing through the jugular foramen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Unilateral lesions of IX and X cranial nerves are commonly caused by skull-base fractures, strokes, or tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Glossopharyngeal and Vagus nerve examination include</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Observing the position and symmetry of the palate and uvula(marked as 2 in the given image) at rest and with phonation (\"aah\").</span></li><li><span style=\"font-size:12.0pt;\">The pharyngeal (gag\") reflex is evaluated by stimulating the posterior pharyngeal wall on each side with a sterile, blunt object (e.g., tongue blade)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Individuals who have a proximal unilateral vagus nerve lesion report having trouble swallowing. On the affected side, the soft palate muscles will be weak. When the patient is asked to utter \"aah,\" for example, an attempt to elevate the soft palate voluntarily will demonstrate a deficit in that side's ability to do so. Due to the palatal muscles' unopposed action on that side, there will also be a deviation of the uvula to the typical side along with this.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option. A. 1:</strong> This area does not relate to the glossopharyngeal or vagus nerves, which are crucial in the described symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option. C. 3</strong>: This area is likely distant from the jugular foramen where nerves IX and X pass, thus not directly involved with the symptoms presented.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option. D. 4:</strong> This lower section of the brain and skull does not typically involve the pathways or exit points of the cranial nerves implicated in swallowing and speech functions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of occipitotemporal fractures with symptoms of difficulty in swallowing and slurred speech, it is critical to assess the function of the glossopharyngeal and vagus nerves, as these are commonly affected by such injuries. Testing should focus on the functionality of the palate and uvula where these nerves can be clinically evaluated.</span></p>",
    "correct_choice_id": 64153,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 24750,
    "choices": [
      {
        "id": 98961,
        "text": "<p><span style=\"font-size:18px;\">Mode is affected by extreme values</span></p>"
      },
      {
        "id": 98962,
        "text": "<p><span style=\"font-size:18px;\">Mean is affected by extreme values</span></p>"
      },
      {
        "id": 98963,
        "text": "<p><span style=\"font-size:18px;\">Median is calculated by overall observations</span></p>"
      },
      {
        "id": 98964,
        "text": "<p><span style=\"font-size:18px;\">Mode can be used as a qualitative data descriptor</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Which of the following statements is false for descriptors of central tendency?</strong><i><strong> [INICET MAY 2023]</strong></i></span></p>",
    "unique_key": "Q8687178",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828660,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Mode is affected by extreme values</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Extreme values in a given dataset do not influence the mode.</span></li><li><span style=\"font-size:18px;\">Mode is the most frequent or most commonly occurring value in a distribution.</span></li><li><span style=\"font-size:18px;\">It is uninfluenced by extreme values and can be used to describe qualitative data</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Mean is affected by extreme values:</strong> This is true. Extreme values (outliers) can significantly affect the mean, making it an unreliable measure of central tendency in skewed distributions.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Median is calculated by overall observations:</strong> This is true. The median is determined by arranging all observations in order and finding the middle value, or the average of the two middle values if the number of observations is even.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Mode can be used as a qualitative data descriptor:</strong> This is true. The mode is applicable to qualitative data as it represents the most frequently occurring category or value.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The mode is not affected by extreme values and can be used to describe qualitative data.</span></li><li><span style=\"font-size:18px;\">In contrast, the mean is affected by extreme values, and the median is a robust measure of central tendency that is calculated using overall observations.</span></li></ul>",
    "correct_choice_id": 98961,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 6945,
    "choices": [
      {
        "id": 27748,
        "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary vasoconstriction</span></p>"
      },
      {
        "id": 27749,
        "text": "<p><span style=\"font-size:12.0pt;\">Polycythemia</span></p>"
      },
      {
        "id": 27750,
        "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
      },
      {
        "id": 27751,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypoxia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following physiological adaptations is generally not observed at high altitudes? (INICET NOV 2022)</span></p>",
    "unique_key": "Q6562217",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828431,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Respiratory acidosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The physiological adaptation that does not happen at high altitudes is respiratory acidosis. Respiratory alkalosis is the physiological adaptation seen at high altitudes due to hyperventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pulmonary vasoconstriction</strong>: Correct, as it is a physiological response to low oxygen levels to improve gas exchange.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Polycythemia</strong>: Correct, as it increases the blood's oxygen-carrying capacity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hypoxia</strong>: Correct, as it is the primary condition caused by low oxygen levels at high altitudes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The principal means by which acclimatization to high altitude comes about are</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">A great increase in pulmonary ventilation - increase in pulmonary ventilation on rising to a high altitude blows off large quantities of carbon dioxide, reducing the Pco2 and increasing the ph of the body fluids.</span></li><li><span style=\"font-size:12.0pt;\">Increased numbers of red blood cells,</span></li><li><span style=\"font-size:12.0pt;\">Increased diffusing capacity of the lungs,</span></li><li><span style=\"font-size:12.0pt;\">Increased vascularity of the peripheral tissues</span></li><li><span style=\"font-size:12.0pt;\">Increased ability of the tissue cells to use oxygen despite low Po2.</span></li><li><span style=\"font-size:12.0pt;\">Cellular Acclimatization - cell mitochondria and cellular oxidative enzyme systems are slightly more plentiful than in sea-level inhabitants</span></li></ol>",
    "correct_choice_id": 27750,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 13683,
    "choices": [
      {
        "id": 54693,
        "text": "<p><span style=\"font-size:12.0pt;\">Great auricular nerve</span></p>"
      },
      {
        "id": 54694,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffLesser occipital nerve</span></p>"
      },
      {
        "id": 54695,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffFacial nerve</span></p>"
      },
      {
        "id": 54696,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffAuriculotemporal nerve</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the prominent nerve pointed in the given image?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/05/untitled-931.jpg\" alt=\"\" width=\"300\" height=\"324\"></span></p><p>&nbsp;</p>",
    "unique_key": "Q1917468",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828550,
    "difficulty_level": "beginner",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Great auricular nerve</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The thickened nerve marked with the arrow in the above image is the great auricular nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/05/image-95.jpg\" alt=\"\" width=\"500\" height=\"509\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Great auricular nerve:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The great auricular nerve is the cervical plexus's largest ascending branch, arising from the anterior rami of spinal nerves C2 and C3.</span></li><li><span style=\"font-size:12.0pt;\">The nerve emerges just behind the sternocleidomastoid muscle's middle portion, curves around its posterior border, and emerges on the muscle's anterior surface.</span></li><li><span style=\"font-size:12.0pt;\">The great auricular nerve perforates the deep cervical fascia and ascends along the external jugular vein, passing under the platysma muscle.</span></li><li><span style=\"font-size:12.0pt;\">The great auricular nerve divides into terminal branches as it approaches the parotid gland.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical considerations:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">\ufeff\ufeff<strong>Leprosy </strong>- Nerve thickening is present. The nerve is palpable over the upper part of the sternocleidomastoid muscle. (As seen in the above image)</span></li><li><span style=\"font-size:12.0pt;\">\ufeff\ufeff<strong>Frey's syndrome -</strong> An aberrant connection between the auriculotemporal nerve and great auricular nerve causes gustatory sweating.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Lesser Occipital Nerve</strong>: The lesser occipital nerve is another branch of the cervical plexus, arising from the second cervical spinal nerve (C2). It provides sensory innervation to the skin over the posterior part of the scalp.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Facial Nerve</strong>: The facial nerve, also known as the seventh cranial nerve (CN VII), is a mixed nerve responsible for controlling the muscles of facial expression. It also carries taste sensation from the anterior two-thirds of the tongue. It does not primarily provide sensory innervation to the skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Auriculotemporal Nerve</strong>: The auriculotemporal nerve is a branch of the mandibular division of the trigeminal nerve (CN V3). It supplies sensory innervation to the external ear and the skin of the temple region.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The great auricular nerve is a branch of the cervical plexus, specifically originating from the second and third cervical spinal nerves (C2-C3). It provides sensory innervation to the skin over the parotid gland, the external ear, and the angle of the mandible.</span></p>",
    "correct_choice_id": 54693,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "OlderNEETPG"
    ]
  },
  {
    "id": 83322,
    "choices": [
      {
        "id": 331888,
        "text": "<p><span style=\"font-size:12.0pt;\">Dolichocephaly</span></p>"
      },
      {
        "id": 331889,
        "text": "<p><span style=\"font-size:12.0pt;\">Mesocephaly</span></p>"
      },
      {
        "id": 331890,
        "text": "<p><span style=\"font-size:12.0pt;\">Brachycephaly</span></p>"
      },
      {
        "id": 331891,
        "text": "<p><span style=\"font-size:12.0pt;\">Trigonocephaly</span></p>"
      }
    ],
    "text": "<p>The anteroposterior diameter of the skull is smallest in which of the following conditions? (NEET PG 2016)</p>",
    "unique_key": "Q6134849",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828421,
    "difficulty_level": "intermediate",
    "subjects_id": [
      10
    ],
    "solution": "<p><strong>Answer: C. Brachycephaly</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Brachycephaly (short-headed) is characterized by a skull that has a short anteroposterior diameter compared to its width. This is reflected in the cephalic index formula:</p><p>Cephalic Index = (Maximum transverse breadth of skull / Maximum anteroposterior length of skull) \u00d7 100</p><p>&nbsp;</p><p>Brachycephalic skulls have a cephalic index of 80-85 and are found in Mongoloids. This high index value indicates that the width is large relative to a shorter anteroposterior length.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Dolichocephaly (Incorrect)</strong> Dolichocephalic (long-headed) skulls have a cephalic index of 70-75. This indicates a longer anteroposterior diameter relative to width, not shorter.</p><p>&nbsp;</p><p><strong>Option B. Mesocephaly (Incorrect)</strong> Mesaticephalic (medium-headed) skulls have a cephalic index of 75-80. This represents an intermediate anteroposterior diameter.</p><p>&nbsp;</p><p><strong>Option D. Trigonocephaly (Incorrect)</strong> Trigonocephaly refers to a condition where the skull has a triangular appearance when viewed from above due to premature fusion of the metopic suture. It's not directly classified in the cephalic index system.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>The cephalic index measures the ratio between skull width and length - the higher the index (as in brachycephaly), the shorter the anteroposterior diameter relative to width.</p>",
    "correct_choice_id": 331890,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 24401,
    "choices": [
      {
        "id": 97565,
        "text": "<p><span style=\"font-size:12.0pt;\">Only 2</span></p>"
      },
      {
        "id": 97566,
        "text": "<p><span style=\"font-size:12.0pt;\">Only 3</span></p>"
      },
      {
        "id": 97567,
        "text": "<p><span style=\"font-size:12.0pt;\">3, 4</span></p>"
      },
      {
        "id": 97568,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is/are correct statement(s) regarding skeletal muscle? (</span>INICET May 2023)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Extracellular calcium entry is important in the skeletal muscle contraction.</span></li><li><span style=\"font-size:12.0pt;\">Calcium is mainly released from mitochondria.</span></li><li><span style=\"font-size:12.0pt;\">Calcium is released from the sarcoplasmic reticulum.</span></li><li><span style=\"font-size:12.0pt;\">Voltage-gated calcium channel on sarcolemma has no role in excitation-contraction coupling.</span></li></ol>",
    "unique_key": "Q2288355",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828430,
    "difficulty_level": "beginner",
    "subjects_id": [
      2
    ],
    "solution": "<p><strong>Ans. B. Only 3</strong></p><p>&nbsp;</p><p>The accurate fact concerning skeletal muscle is that the release of calcium occurs from the sarcoplasmic reticulum only.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p>1. Extracellular calcium plays a significant role in sustaining cardiac muscle contraction , not in skeletal muscle.</p><p>&nbsp;</p><p>2. The sarcoplasmic reticulum is filled with high concentrations of calcium ions stored in its vesicular tubules. Upon the occurrence of an action potential in the neighboring T tubule, these calcium ions are discharged from each vesicle.</p><p>&nbsp;</p><p>4. Activation of &nbsp;voltage-gated calcium channel is essential in excitation-contraction coupling, i.e. it a has important role. Activation of receptor results in the initiation of calcium release from RyR channels, leading to the liberation of calcium ions from the sarcoplasm surrounding the myofibrils, consequently triggering muscle contraction.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>The release of calcium from the sarcoplasmic reticulum is essential for skeletal muscle contraction.</p>",
    "correct_choice_id": 97566,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 13912,
    "choices": [
      {
        "id": 55609,
        "text": "<p><span style=\"font-size:12.0pt;\">Scalp, dura, arachnoid</span></p>"
      },
      {
        "id": 55610,
        "text": "<p><span style=\"font-size:12.0pt;\">Scalp, epicranium, endocranium and dura</span></p>"
      },
      {
        "id": 55611,
        "text": "<p><span style=\"font-size:12.0pt;\">Scalp, synchondral membrane, dura, arachnoid</span></p>"
      },
      {
        "id": 55612,
        "text": "<p><span style=\"font-size:12.0pt;\">Pericranium, dura, arachnoid</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 6-month-old boy was brought to the casualty with seizures. The pediatrician tries to do CSF sampling. What are the structures punctured by the pediatrician while piercing through the marked structure? (</span>INICET May 2021)</p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-63_Z2kvTec.jpg\" alt=\"\" width=\"273\" height=\"357\"></span></p>",
    "unique_key": "Q3949125",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828448,
    "difficulty_level": "intermediate",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Scalp, dura, arachnoid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The arrow in the illustration, which displays a baby's skull, is pointing in the direction of the anterior fontanelle. Ventricular tapping is the term used to describe the process of removing CSF from the anterior fontanelle. The various structures pierced are the scalp, dura, and arachnoid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Fontanelle tap/ Percutaneous ventricular puncture:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Infants who need urgent ventricular decompression and have an open anterior fontanelle and no access to a VP shunt undergo a fontanelle tap or percutaneous ventricular puncture. A butterfly needle is used to immediately puncture the infant's open fontanelle and enter the lateral ventricle in order to obtain CS samples, alleviate pressure, or insert a drain or catheter.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Procedure: A 25-gauge butterfly needle is inserted through the anterolateral aspect of the anterior fontanelle (away from the midline, avoiding the superior sagittal sinus).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When performing a fontanelle tap, the following layers are pierced:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Scalp</strong>: This includes the skin and the underlying connective tissue of the scalp.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Membranous fontanelle</strong>: The actual fontanelle is a soft spot on a baby's head where the bones of the skull have not yet fused together. It's a membranous gap between the cranial bones.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Dura mater</strong>: The tough outermost membrane of the three layers of the meninges that surround the brain and spinal cord.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Arachnoid mater</strong>: A thin, wispy layer that lies underneath the dura mater.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Cerebrospinal fluid (CSF)</strong>: Once through the arachanoid mater, the needle enters the subarachnoid space where the CSF is located.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note: The fontanelle tap bypasses the bony skull, which is why it's an accessible route in neonates and infants for procedures that require access to the CSF. However, as the child grows, these fontanelles close, and the method is no longer viable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fontanelle tap is a critical emergency procedure used in infants for CSF sampling or pressure relief from the ventricles, exploiting the unossified sections of the skull for direct access to the CSF. This procedure is unique to neonates and young infants where the fontanelle is present and typically involves piercing the scalp, dura, and arachnoid layers.</span></p>",
    "correct_choice_id": 55609,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET",
      "InvestigationBased"
    ]
  },
  {
    "id": 49021,
    "choices": [
      {
        "id": 195659,
        "text": "<p><span style=\"font-size:18px;\">MR SC and Oral Vitamin A at 8 months</span></p>"
      },
      {
        "id": 195660,
        "text": "<p><span style=\"font-size:18px;\">MR IM and Oral Vitamin A at 8 months</span></p>"
      },
      {
        "id": 195661,
        "text": "<p><span style=\"font-size:18px;\">MR SC and Oral Vitamin A at 9 months</span></p>"
      },
      {
        "id": 195662,
        "text": "<p><span style=\"font-size:18px;\">MR IM and Oral Vitamin A at 9 months</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>What is the schedule and route of administration of MR vaccine: </strong><i><strong>[INICET NOV 2023]</strong></i></span></p>",
    "unique_key": "Q2202682",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828659,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) MR SC and Oral Vitamin A at 9 months</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C : MR Sc and Oral Vitamin A at 9 months</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">This option is correct as per the National Immunization Schedule. The MR vaccine is given subcutaneously at 9 completed months along with the first dose of Vitamin A, aligning with the guidelines for both treatments.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Vitamin A Supplementation schedule</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/13/screenshot-2024-06-13-110944.JPG\" alt=\"\" width=\"1000\" height=\"204\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In total \u2013 9 doses \u2013 17 Lacs IU</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Measles vaccine schedule</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/13/screenshot-2024-06-13-111150.JPG\" alt=\"\" width=\"1000\" height=\"923\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The MR vaccine should be administered subcutaneously at 9 completed months, and the first dose of Vitamin A should be given concurrently. This regimen helps to ensure optimal immune response and nutritional support, which is crucial for preventing measles, rubella, and vitamin A deficiency-related health issues.</span></p>",
    "correct_choice_id": 195661,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 7081,
    "choices": [
      {
        "id": 28292,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tmax</span></span></span></p>"
      },
      {
        "id": 28293,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Area under the curve</span></span></span></p>"
      },
      {
        "id": 28294,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cmax</span></span></span></p>"
      },
      {
        "id": 28295,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">t1/2</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The extent of drug absorption in plasma concentration vs time graph is represented by:</span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q4893792",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828416,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Area under the curve</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Area under the curve (AUC) is a measure of the total drug exposure in the bloodstream over time. It reflects the total amount of drug absorbed and is often used to assess the overall bioavailability of a drug. AUC is crucial for determining the efficacy and safety of a medication.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Tmax (Time to Maximum Concentration):</span></strong><span style=\"font-size:12.0pt\"> Tmax represents the time it takes for a drug to reach its maximum concentration (Cmax) in the bloodstream. It tells about rate of drug absorption. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cmax (Maximum Concentration):</span></strong><span style=\"font-size:12.0pt\"> Cmax represents the highest concentration of a drug in the bloodstream after administration. This parameter is important because it indicates the peak therapeutic effect and helps assess the risk of side effects associated with high drug concentrations.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. t1/2 (Half-Life):</span></strong><span style=\"font-size:12.0pt\"> t1/2 is the time it takes for half of the drug to be eliminated from the bloodstream. It is not directly related to drug absorption but is essential in understanding how long a drug remains in the body and how often it needs to be administered.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Area Under the Curve (AUC) in a plasma concentration vs. time graph represents the extent of drug absorption, reflecting the total drug exposure over time and the overall bioavailability of the drug.</span></span></span></p>",
    "correct_choice_id": 28293,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 6658,
    "choices": [
      {
        "id": 26601,
        "text": "<p><span style=\"font-size:12.0pt;\">It most commonly affects ages 35-45 years</span></p>"
      },
      {
        "id": 26602,
        "text": "<p><span style=\"font-size:12.0pt;\">Type 1 is common in both sexes</span></p>"
      },
      {
        "id": 26603,
        "text": "<p><span style=\"font-size:12.0pt;\">Prevalence in general population is 1-2%</span></p>"
      },
      {
        "id": 26604,
        "text": "<p><span style=\"font-size:12.0pt;\">Attempt to commit suicide is seen around 15% of people</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is false about bipolar disorder? (</span>INICET May 2022)</p>",
    "unique_key": "Q1308185",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828657,
    "difficulty_level": "intermediate",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) It most commonly affects ages 35-45 years</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bipolar disorder, historically called manic-depressive illness, often begins in late adolescence or early adulthood. While it can start in childhood or later in life, this is less common.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Type 1 is common in both sexes:</strong> True. Bipolar I disorder has no gender bias and affects men and women equally.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Prevalence in the general population is 1-2%: </strong>True. Bipolar disorder affects about 1-2% of the global population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Attempt to commit suicide is seen in around 15% of people:</strong> True. People with bipolar disorder have a high suicide risk, and approximately 15% may end up taking their own life.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bipolar disorder typically presents in late adolescence or early adulthood. It is characterized by episodes of mania and depression, affects both sexes equally, has a prevalence of 1-2% in the general population, and carries a significant risk of suicide.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock\u2019s Synopsis of Psychiatry, 12th edition, Page No 376.</strong></span></p>",
    "correct_choice_id": 26601,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 6460,
    "choices": [
      {
        "id": 25809,
        "text": "<p><span style=\"font-size:12.0pt;\">C is competitive antagonist</span></p>"
      },
      {
        "id": 25810,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffC is more potent than A</span></p>"
      },
      {
        "id": 25811,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffB is more potent than A</span></p>"
      },
      {
        "id": 25812,
        "text": "<p><span style=\"font-size:12.0pt;\">B is competitive antagonist</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true regarding the dose-response curve shown in the image below?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/204.jpg\" alt=\"\" width=\"400\" height=\"267\"></span></p>",
    "unique_key": "Q2956008",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828424,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) B is competitive antagonist</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This questions tests the knowledge regarding two different things about dose response curve:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">a. Potency and Efficacy: Remember, to take HELP whenever in doubt. It means Height of the curve tells about Efficacy (higher the curve, the more efficacious the drug is) and Left sidedness of the curve tells about Potency (Drugs with curves on left side are more potent than drugs with curve on right side)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">b. Type of Inhibition: If the curve shifts parallelly to right, the drug is a competitive inhibitor, if it shifts down, the drug is a non-competitive inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>What is given in graph:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The DRC of drug B has shifted to the right of the DRC of drug A , although the height of the two curves is the same. On the other hand, Drug C has shifted the curve down.</span></li><li><span style=\"font-size:12.0pt;\">Further height of curve in Drug A and B is same but more than Drug C.</span></li><li><span style=\"font-size:12.0pt;\">Curve of Drug A is on most left followed by Drug C and then Drug B.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Inferences:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, the following inferences can be drawn from the given image:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The efficacy of Drug A = Drug B &gt; Drug C</span></li><li><span style=\"font-size:12.0pt;\">The Potency of Drug A &gt; Drug C &gt; Drug B</span></li><li><span style=\"font-size:12.0pt;\">Drug B is a competitive inhibitor of Drug A</span></li><li><span style=\"font-size:12.0pt;\">Drug C is a non-competitive inhibitor of Drug A</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Efficacy</strong>: The height of the curve represents the efficacy of the drug. The higher the curve, the more efficacious the drug.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Potency</strong>: The position of the curve along the x-axis (left or right) indicates the potency. Drugs with curves on the left side are more potent than those on the right side.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Type of Inhibition</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Competitive Inhibition</strong>: A competitive inhibitor will shift the dose-response curve to the right without changing the maximum effect (efficacy). This indicates that higher concentrations of the agonist can overcome the inhibition.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Non-Competitive Inhibition</strong>: A non-competitive inhibitor will reduce the maximum effect (efficacy) of the agonist, causing a downward shift in the dose-response curve.</span></li></ul>",
    "correct_choice_id": 25812,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "OlderNEETPG"
    ]
  },
  {
    "id": 7029,
    "choices": [
      {
        "id": 28084,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Hydrocortisone</span></p>"
      },
      {
        "id": 28085,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Potassium binding resin</span></p>"
      },
      {
        "id": 28086,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Digoxin</span></p>"
      },
      {
        "id": 28087,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Calcium gluconate</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">An 18-month-old child with ambiguous genitalia presented to the hospital, his </span><span style=\"font-size:12.0pt;\">BP is 88/68 mm Hg</span><span style=\"font-size:12pt;\">, Serum K<sup>+</sup> is 6 mEq/L, serum sodium is 120 mEq/L. Patient was started on intravenous fluids. What additional specific therapy will you add?</span></p>",
    "unique_key": "Q9436180",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828412,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Hydrocortisone</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The presentation of an 18-month-old child with ambiguous genitalia, hypertension (BP is 88/68 mm Hg, which is low for this age), hyperkalemia (serum K of 6 mEq/L), and hyponatremia (serum sodium of 120 mEq/L) is suggestive of congenital adrenal hyperplasia (CAH), most likely due to 21-hydroxylase deficiency. This is a common form of CAH and can lead to a decrease in cortisol and aldosterone production, with an accompanying increase in adrenal androgens.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Given this clinical picture, the specific therapy to be added would include:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ol><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Glucocorticoid Replacement:</strong> This is critical to suppress the overproduction of adrenal androgens. Hydrocortisone is commonly used, especially in pediatric patients, due to its short duration of action and lower impact on growth.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Mineralocorticoid Replacement:</strong> Fludrocortisone is usually added to manage the aldosterone deficiency, which is contributing to the hyperkalemia and hyponatremia.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Sodium Chloride Supplements:</strong> In some cases, especially in infants and young children, additional sodium chloride supplements may be necessary to manage hyponatremia.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Monitoring and Adjustment:</strong> Regular monitoring of electrolytes, blood pressure, and growth is necessary to adjust therapy accordingly.</span></p></li></ol><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B</strong>. <strong>Potassium Binding Resins:</strong> While these can be used to treat hyperkalemia, they do not address the underlying cause of the electrolyte imbalance in this scenario, which is likely due to aldosterone deficiency. Therefore, it would not be the first choice.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C</strong>. <strong>Digoxin:</strong> This is used primarily for heart failure and certain arrhythmias, not for the conditions described in this scenario.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D</strong>. <strong>Calcium Gluconate:</strong> This is used in the acute management of severe hyperkalemia to stabilize cardiac membranes. While it might be used in an emergency setting for life-threatening hyperkalemia, it does not address the underlying cause in this case and is not a long-term management strategy.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Therefore, the most appropriate addition to this patient's treatment regimen would be <strong>Hydrocortisone</strong> (option a), as it addresses the underlying cause of the symptoms in CAH. Additionally, monitoring and adjusting mineralocorticoid therapy (like fludrocortisone) would be important in the long-term management, especially given the electrolyte imbalances.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The most appropriate addition to this patient's treatment regimen would be Hydrocortisone, as it addresses the underlying cause of the symptoms in CAH. Additionally, monitoring and adjusting mineralocorticoid therapy (like fludrocortisone) would be important in the long-term management, especially given the electrolyte imbalances.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/314</strong></span></p>",
    "correct_choice_id": 28084,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 7117,
    "choices": [
      {
        "id": 28436,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Safety in pregnancy</span></span></span></p>"
      },
      {
        "id": 28437,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dose adjustment in renal failure</span></span></span></p>"
      },
      {
        "id": 28438,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cost ratio from cheap to expensive</span></span></span></p>"
      },
      {
        "id": 28439,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">As per safety or therapeutic index</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Category A, B, C, D, X in drug classification is indicative of which of the following?(INICET NOV 2021)</span></span></span></p>",
    "unique_key": "Q7469157",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828417,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Safety in pregnancy</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The categories A, B, C, D, and X are used to classify drugs based on their safety during pregnancy. This classification helps in determining the potential risk of medications to the fetus when taken during pregnancy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pregnancy drug category, which are indicative of their safety are as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Category A &gt; B &gt; C &gt; D &gt; X</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-165435.jpg\" style=\"height:434px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Dose adjustment in renal failure: </span></strong><span style=\"font-size:12.0pt\">Drug classifications for dose adjustments in renal failure typically involve guidelines based on the drug&#39;s pharmacokinetics and renal clearance. These guidelines are not categorized as A, B, C, D, X.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cost ratio from cheap to expensive</span></strong><span style=\"font-size:12.0pt\">: Drug classifications based on cost are not typically denoted by the categories A, B, C, D, X. Cost-related classifications might be discussed in economic terms or based on generic versus brand name distinctions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. As per safety or therapeutic index</span></strong><span style=\"font-size:12.0pt\">: The therapeutic index of a drug, which measures its safety margin, is not categorized using the A, B, C, D, X system. The therapeutic index is a ratio comparing the toxic dose to the therapeutic dose, but it is not classified in this alphabetical manner.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The classification of drugs into categories A, B, C, D, and X is specifically used to indicate their safety during pregnancy, helping healthcare providers to make informed decisions about medication use in pregnant patients.</span></span></span></p>",
    "correct_choice_id": 28436,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 73224,
    "choices": [
      {
        "id": 291853,
        "text": "<p><span style=\"color:black;font-size:16px;\">1-C, 2-B, 3-D, 4-A</span></p>"
      },
      {
        "id": 291854,
        "text": "<p><span style=\"color:black;font-size:16px;\">1-D, 2-A, 3-C, 4-B</span></p>"
      },
      {
        "id": 291855,
        "text": "<p><span style=\"color:black;font-size:16px;\">1-A, 2-B, 3-C, 4-D</span></p>"
      },
      {
        "id": 291856,
        "text": "<p><span style=\"color:black;font-size:16px;\">1-B, 2-D, 3-A, 4-C&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Match the Following hormones to receptors: (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cz4tr8D.png\" width=\"877\" height=\"236\"></span></p>",
    "unique_key": "Q2240697",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828427,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) 1-A, 2-B, 3-C, 4-D</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Insulin - Tyrosine Kinase Pathway:&nbsp;</strong>Insulin uses a tyrosine kinase receptor. This is a cell surface receptor that, when activated, phosphorylates tyrosine residues on target proteins, triggering intracellular signaling cascades.</span></li><li><span style=\"font-size:16px;\"><strong>Growth Hormone - JAK-STAT Pathway:&nbsp;</strong>Growth hormone, along with prolactin and leptin, uses the JAK-STAT (Janus Kinase-Signal Transducer and Activator of Transcription) pathway. This is a cytokine receptor-mediated signaling mechanism.</span></li><li><span style=\"font-size:16px;\"><strong>Acetylcholine - Ligand-gated Channel:&nbsp;</strong>At the neuromuscular junction, acetylcholine operates through ligand-gated sodium channels. When acetylcholine binds, these channels open, allowing sodium ions to flow and triggering muscle contraction.</span></li><li><span style=\"font-size:16px;\"><strong>Levothyroxine (Thyroid Hormone) - Nuclear Receptor:&nbsp;</strong>Thyroid hormones act through nuclear receptors, which means they enter the cell and directly interact with DNA in the nucleus to regulate gene expression.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Classification of Receptors</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Jzaqqro.png\" width=\"1221\" height=\"636\"></strong></span></p>",
    "correct_choice_id": 291855,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 6894,
    "choices": [
      {
        "id": 27544,
        "text": "<p><span style=\"font-size:12.0pt;\">Myocardial contractility</span></p>"
      },
      {
        "id": 27545,
        "text": "<p><span style=\"font-size:12.0pt;\">Stroke volume</span></p>"
      },
      {
        "id": 27546,
        "text": "<p><span style=\"font-size:12.0pt;\">Arterial wall compliance</span></p>"
      },
      {
        "id": 27547,
        "text": "<p><span style=\"font-size:12.0pt;\">Cardiac output</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old patient visits his family practitioner for a yearly examination. On examination, his BP was 190/100 mm Hg. His pulse pressure was 90 mm Hg. What would have decreased resulting in this increase in pulse pressure?(INICET NOV 2020)</span></p>",
    "unique_key": "Q3935257",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828435,
    "difficulty_level": "beginner",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Arterial wall compliance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pulse pressure is the difference between systolic and diastolic blood pressure, and it reflects the compliance (elasticity) of the arterial walls. In this scenario, the patient has a high systolic blood pressure and a normal diastolic blood pressure, resulting in an increased pulse pressure of 90 mm Hg (190 mm Hg - 100 mm Hg = 90 mm Hg).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Arterial wall compliance refers to the ability of the arteries to expand and contract with each heartbeat, which helps maintain a steady blood pressure. Decreased arterial wall compliance leads to increased stiffness of the arteries, which can cause an increase in systolic blood pressure and pulse pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Myocardial contractility:</strong> Incorrect. While myocardial contractility can influence blood pressure, it is not directly related to the increase in pulse pressure in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Stroke volume:</strong> Incorrect. Stroke volume affects cardiac output and overall blood pressure but is not the primary factor in the increase in pulse pressure observed here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Cardiac output:</strong> Incorrect. Cardiac output can affect overall blood pressure, but the specific increase in pulse pressure in this case is more closely linked to decreased arterial wall compliance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Decreased arterial wall compliance leads to increased stiffness of the arteries, resulting in higher systolic blood pressure and an increased pulse pressure, as observed in the patient.</span></p>",
    "correct_choice_id": 27546,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 19951,
    "choices": [
      {
        "id": 79765,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Functional residual capacity</span></span></span></p>"
      },
      {
        "id": 79766,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tidal volume</span></span></span></p>"
      },
      {
        "id": 79767,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Expiratory reserve volume</span></span></span></p>"
      },
      {
        "id": 79768,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Expiratory capacity</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Identify the marked area in the given spirometry graph?&nbsp;</span></span></span>&nbsp;(NEET PG 2023)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/27/physiology-neet-23-1-1.jpg\" style=\"height:407px; width:400px\" /></span></span></p>",
    "unique_key": "Q3360064",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828441,
    "difficulty_level": "beginner",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Functional residual capacity </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The marked area in the spirometry graph indicates the <strong>Functional Residual Capacity (FRC)</strong>. FRC is the volume of air remaining in the lungs after a normal, passive exhalation. This is not fully expelled during a standard tidal cycle and represents the air that remains in the lungs to keep them inflated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">FRC Components</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">FRC includes the Expiratory Reserve Volume (ERV) plus the Residual Volume (RV).</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ERV is the additional air that can be forcibly exhaled after the end of a normal, calm exhalation.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">RV is the volume of air still remaining in the lungs after the most forceful exhalation, which cannot be voluntarily expelled.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/27/physiology-neet-23-1-2.jpg\" style=\"height:435px; width:700px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Significance in Spirometry:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In spirometry:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">FRC</span></strong><span style=\"font-size:12.0pt\"> is critical for maintaining the alveolar inflation and preventing the airways from collapsing.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is not directly measurable by simple spirometry because it includes the residual volume. Techniques such as body plethysmography or using tracer gas dilution methods are usually employed to measure FRC.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Tidal Volume (TV or VT)</span></strong><span style=\"font-size:12.0pt\">: This is the volume of air inhaled or exhaled during a normal breathing cycle, not indicated in this context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Expiratory Reserve Volume (ERV)</span></strong><span style=\"font-size:12.0pt\">: Part of FRC, this is the maximum volume of air that can be voluntarily expelled after the end of a normal, passive exhalation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Expiratory Capacity</span></strong><span style=\"font-size:12.0pt\">: It is the total amount of air that can be expired from the lungs after a maximal inhalation, typically including the tidal volume plus the expiratory reserve volume, not specifically marked here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Functional Residual Capacity (FRC) is the volume of air remaining in the lungs after a normal expiration and is essential for preventing lung collapse and maintaining pulmonary function, especially during physical activities or respiratory challenges. Understanding FRC&#39;s role helps in assessing lung health and diagnosing potential respiratory disorders.</span></span></span></p>",
    "correct_choice_id": 79765,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 6919,
    "choices": [
      {
        "id": 27644,
        "text": "<p><span style=\"font-size:12.0pt;\">a wave</span></p>"
      },
      {
        "id": 27645,
        "text": "<p><span style=\"font-size:12.0pt;\">c wave</span></p>"
      },
      {
        "id": 27646,
        "text": "<p><span style=\"font-size:12.0pt;\">x descent</span></p>"
      },
      {
        "id": 27647,
        "text": "<p><span style=\"font-size:12.0pt;\">y descent</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following jugular venous pressure (JVP) waves corresponds to the isovolumetric contraction phase of the cardiac cycle? (INICET NOV 2021)</span></p>",
    "unique_key": "Q8583566",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828433,
    "difficulty_level": "beginner",
    "subjects_id": [
      2
    ],
    "solution": "<p><strong>Ans. B) c wave</strong></p><p>&nbsp;</p><p>The jugular venous pressure (JVP) waveform consists of multiple waves that correspond to different phases of the cardiac cycle.</p><p>&nbsp;</p><p>The <strong>\"c\" wave</strong> corresponds to the bulging of the tricuspid valve into the right atrium during <strong>ventricular contraction</strong>, causing a brief increase in pressure in the right atrium.</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><strong>Option A.</strong> The \"a\" wave corresponds to the atrial contraction, which occurs during the late ventricular filling phase of the cardiac cycle. This is the period before the closure of the mitral/ tricuspid valve. The \"a\" wave is caused by the contraction of the atrium, leading to a brief increase in right atrial pressure.</p><p>&nbsp;</p><p><strong>Option C.</strong> The \"x\" descent corresponds to the returning of the tricuspid valve to its normal position during ventricular contraction (i.e. ejection) and atrial relaxation.</p><p>&nbsp;</p><p><strong>Option D.</strong> The \"y\" descent corresponds to the rapid emptying of the right atrium into the right ventricle during ventricular diastole.</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/physiology-nov-1-1.jpg\" alt=\"\" width=\"600\" height=\"330\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>The \"c\" wave of the jugular venous pressure waveform corresponds to the isovolumetric contraction phase of the cardiac cycle, reflecting the bulging of the tricuspid valve into the right atrium as the right ventricle begins to contract.</p>",
    "correct_choice_id": 27645,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 13765,
    "choices": [
      {
        "id": 55021,
        "text": "<p><span style=\"font-size:12.0pt;\">Extensor pollicis brevis and abductor pollicis longus</span></p>"
      },
      {
        "id": 55022,
        "text": "<p><span style=\"font-size:12.0pt;\">Extensor pollicis longus and abductor pollicis brevis</span></p>"
      },
      {
        "id": 55023,
        "text": "<p><span style=\"font-size:12.0pt;\">Extensor pollicis longus and extensor pollicis brevis</span></p>"
      },
      {
        "id": 55024,
        "text": "<p><span style=\"font-size:12.0pt;\">Abductor pollicis longus and abductor pollicis brevis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following forms the lateral boundary of the anatomical snuff box?&nbsp;</span><span style=\"font-size:11pt;\">(NEET PG 2020)</span></p>",
    "unique_key": "Q6786395",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828552,
    "difficulty_level": "beginner",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Extensor pollicis brevis and abductor pollicis longus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The anatomical snuffbox is a triangular depression located on the lateral aspect of the wrist and the base of the thumb. When the thumb is extended, this depression becomes more pronounced.<strong> </strong>The lateral boundary of the anatomical snuff box is formed by extensor pollicis brevis and abductor pollicis longus. When you extend and abduct the thumb, you can typically feel these tendons, especially the abductor pollicis longus, become taut along the lateral border of the wrist, outlining the snuffbox.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-093028.png\" alt=\"\" width=\"500\" height=\"540\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Extensor pollicis longus and abductor pollicis brevis</strong>: The extensor pollicis longus forms the medial boundary of the anatomical snuffbox. It extends the thumb's distal phalanx. The abductor pollicis brevis is a muscle of the thenar eminence and doesn't directly contribute to the boundaries of the anatomical snuffbox. Its tendon is not found in this region; instead, it inserts into the base of the thumb's proximal phalanx.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Extensor pollicis longus and extensor pollicis brevis</strong>: As already mentioned, the extensor pollicis longus forms the medial boundary of the anatomical snuffbox. The extensor pollicis brevis, in conjunction with the abductor pollicis longus, forms the lateral boundary. However, they don't together form just one boundary of the snuffbox.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Abductor pollicis longus and abductor pollicis brevis</strong>: The abductor pollicis longus contributes to the lateral boundary of the snuffbox, as mentioned above. The abductor pollicis brevis, on the other hand, doesn't form any part of the snuffbox boundaries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-26%20141437.png\" width=\"1169\" height=\"750\"></p>",
    "correct_choice_id": 55021,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 6504,
    "choices": [
      {
        "id": 25985,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To prevent teratogenic effects </span></span></span></p>"
      },
      {
        "id": 25986,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To avoid failure of ATT </span></span></span></p>"
      },
      {
        "id": 25987,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Because rifampicin can decrease OCP metabolism </span></span></span></p>"
      },
      {
        "id": 25988,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Because rifampicin can induce OCP metabolism and cause failure</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old female patient has been diagnosed with tuberculosis and is about to begin antitubercular therapy (ATT) that includes rifampicin. She is currently taking oral contraceptives (OCP) for birth control. The clinician advises her to use an additional barrier method of contraception while undergoing treatment. What is the primary reason for this recommendation?</span></span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2021)</span></span></p>",
    "unique_key": "Q5541146",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828426,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Because rifampicin can induce OCP metabolism and cause failure</span></strong><strong> </strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rifampicin is used as one of the first line drugs against tuberculosis. Rifampicin is an enzyme inducer, that induces the cytochrome P450 enzymes. Therefore, this leads to increased rate of metabolism of the OCPs, thereby leading to contraceptive failure. So, in a female receiving ATT, it is advised to use additional barrier methods of contraception apart from OCPs.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. To prevent teratogenic effects</span></strong><span style=\"font-size:12.0pt\">: Most of the antitubercular drugs including rifampicin, isoniazid and ethambutol are safe in pregnancy. Further she is already taking OCPs, so the examiner does not want to ask about teratogenic effect of antitubercular drugs.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. To avoid failure of ATT</span></strong><span style=\"font-size:12.0pt\">: The interaction between ATT and OCP does not lead to the failure of antitubercular therapy; rather, it affects the efficacy of the oral contraceptive method.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Because rifampicin can decrease OCP metabolism</span></strong><span style=\"font-size:12.0pt\">: This is incorrect because rifampicin actually induces, rather than decreases, the metabolism of oral contraceptives. This can lead to reduced levels of contraceptive hormones in the blood, thereby potentially leading to contraceptive failure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rifampicin is known to induce hepatic enzymes that speed up the metabolism of various drugs, including oral contraceptives. This can lead to lower blood levels of the hormones in OCPs, thereby reducing their efficacy and increasing the risk of contraceptive failure. Hence, it is advised for patients on both medications to use an additional barrier method of contraception.</span></span></span></p>",
    "correct_choice_id": 25988,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 7150,
    "choices": [
      {
        "id": 28568,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers</span></span></span></p>"
      },
      {
        "id": 28569,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium channel blockers</span></span></span></p>"
      },
      {
        "id": 28570,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetaminophen</span></span></span></p>"
      },
      {
        "id": 28571,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization will be most useful in toxicity of which of the following drugs? (INICET NOV 2020)</span></span></p>",
    "unique_key": "Q3639351",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828415,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Aspirin</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization is a key treatment in aspirin toxicity. Aspirin (salicylate) is a weak acid, and alkalinizing the urine increases the ionization of salicylates. This ionization traps salicylates in the urine, preventing their reabsorption and enhancing their elimination.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Beta blockers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Urinary alkalinization is not a standard treatment for beta blocker toxicity. Management of beta blocker overdose typically involves supportive care and, in severe cases, specific antidotes like glucagon or high-dose insulin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Calcium channel blockers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Similar to beta blockers, urinary alkalinization is not a primary treatment for calcium channel blocker overdose. Treatment often includes calcium infusions, glucagon, and other supportive measures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Acetaminophen:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> For acetaminophen toxicity, the antidote N-acetylcysteine (NAC) is used. Urinary alkalinization is not effective for acetaminophen overdose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization is most useful in the treatment of aspirin (salicylate) toxicity because it increases the elimination of salicylates by trapping them in the urine through ionization. This method is not effective for beta blockers, calcium channel blockers, or acetaminophen toxicity.</span></span></span></p>",
    "correct_choice_id": 28571,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 51002,
    "choices": [
      {
        "id": 203545,
        "text": "<p><span style=\"font-size:12pt;\">A-4, B-3, C-2, D-1</span></p>"
      },
      {
        "id": 203546,
        "text": "<p><span style=\"font-size:12pt;\">A-4, B-2, C-3, D-1</span></p>"
      },
      {
        "id": 203547,
        "text": "<p><span style=\"font-size:12pt;\">A-2, B-1, C-4, D-3</span></p>"
      },
      {
        "id": 203548,
        "text": "<p><span style=\"font-size:12pt;\">A-2, B-3, C-4, D-1</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Match the following muscles with their action at shoulder joint: (INICET NOV 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-03-180933.png\" alt=\"\" width=\"700\" height=\"180\"></span></p>",
    "unique_key": "Q2852717",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828444,
    "difficulty_level": "intermediate",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) A-2, B-3, C-4, D-1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>A. Latissimus dorsi:</strong> This muscle is known as the \"stand at ease\" muscle, the \"climbers muscle,\" and the \"swimmers muscle.\" It originates from the back and inserts into the front between two major muscles. When it contracts, it causes backward movement, extension, adduction, and medial rotation of the shoulder. Therefore, its action is <strong>extension with medial rotation</strong> <strong>(Action 2).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>B. Supraspinatus:</strong> Located above the spine of the scapula, the supraspinatus muscle, when it contracts, moves the arm away from the midline, which is known as abduction. Hence, its action is <strong>abduction</strong> <strong>(Action 3).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>C. Infraspinatus:</strong> This muscle originates from the back and rotates the arm outward when it contracts, causing lateral rotation. Thus, its action is <strong>lateral rotation</strong> <strong>(Action 4).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>D. Pectoralis Major (sternal head):</strong> Originating from the midline (sternum and clavicle) and inserting into the lateral lip of the intertubercular sulcus, this muscle, when contracted, causes movement to the front (flexion). Therefore, its action is <strong>flexion</strong> <strong>(Action 1).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Latissimus dorsi</strong> is responsible for <strong>extension with medial rotation</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Supraspinatus</strong> is responsible for <strong>abduction</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Infraspinatus</strong> is responsible for <strong>lateral rotation</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Pectoralis Major (sternal head)</strong> is responsible for <strong>flexion</strong>.</span></li></ul>",
    "correct_choice_id": 203548,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 73689,
    "choices": [
      {
        "id": 293697,
        "text": "<p><span style=\"font-size:16px;\">Maraviroc</span></p>"
      },
      {
        "id": 293698,
        "text": "<p><span style=\"font-size:16px;\">Ibalizumab</span></p>"
      },
      {
        "id": 293699,
        "text": "<p><span style=\"font-size:16px;\">Fostemsavir</span></p>"
      },
      {
        "id": 293700,
        "text": "<p><span style=\"font-size:16px;\">Tenofovir</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following drug binds to CD4 receptors and is used for both CCR-5 as well as CXCR-4 tropic HIV?&nbsp;(INICET NOV 2024)</span></p>",
    "unique_key": "Q6693775",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828411,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Ibalizumab</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">Ibalizumab is a post-attachment inhibitor that binds to CD4 receptors. After HIV attaches to CD4 via GP120, ibalizumab prevents the conformational change in the CD4 receptor that is necessary for viral entry. Since it acts directly on CD4 receptors, it is effective against both CCR5 and CXCR4-tropic HIV strains.</span></p><p><br><span style=\"font-size:16px;\"><strong>Entry Inhibitors</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-08%20114941.jpg\" width=\"788\" height=\"330\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-08%20114953.jpg\" width=\"1141\" height=\"529\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\"><strong>Option A. Maraviroc</strong>: This is a CCR5 co-receptor antagonist. It only works against CCR5-tropic HIV and is ineffective against CXCR4-tropic strains.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Fostemsavir:</strong> This is an attachment inhibitor that binds to viral GP120, preventing initial attachment to CD4 receptors. It does not bind to CD4 receptors directly.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Tenofovir</strong>: This is a Nucleotide Reverse Transcriptase Inhibitor (NRTI). It works after viral entry by inhibiting viral DNA synthesis. It does not affect viral entry or bind to CD4 receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">Ibalizumab is a post-attachment inhibitor that binds to CD4 receptors and prevents HIV from entering T-cells by inhibiting conformational changes required for interaction with CCR5 and CXCR4 co-receptors. It is useful in multidrug-resistant HIV cases where other entry inhibitors like Maraviroc (CCR5-specific) are ineffective.</span><br><br><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-08%20115024.jpg\" width=\"1106\" height=\"345\"></span></p>",
    "correct_choice_id": 293698,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 8774,
    "choices": [
      {
        "id": 35063,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NO</span></span></span></p>"
      },
      {
        "id": 35064,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Noradrenaline</span></span></span></p>"
      },
      {
        "id": 35065,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Opening of calcium channels</span></span></span></p>"
      },
      {
        "id": 35066,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adenosine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">According to myogenic hypothesis of renal autoregulation, the afferent arterioles contract in response to stretch-induced by?&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">(NEET PG 2019)</span></span></p>",
    "unique_key": "Q2426020",
    "question_audio": null,
    "question_video": null,
    "map_id": 34828437,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Opening of calcium channels </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Renal autoregulation is important to maintain the glomerular filtration rate (GFR). Blood flow to kidneys remains normal even when the mean arterial blood pressure varies widely between 60 mm Hg and 180 mm Hg. This helps to maintain normal GFR.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Two mechanisms are involved in renal autoregulation:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myogenic response</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tubuloglomerular feedback<strong> (TGF)</strong></span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1. MYOGENIC RESPONSE</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Whenever, the blood flow to kidneys increases, &nbsp;</span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:Symbol\">&rarr;</span></span> &nbsp;</strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">stretches the elastic wall of the afferent arteriole </span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:Symbol\">&rarr;</span></span>&nbsp; </strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stretching of the vessel wall increases the flow of calcium ions from extracellular fluid into the cells </span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:Symbol\">&rarr;</span></span></strong><strong> </strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;The influx of calcium ions leads to the contraction of smooth muscles in afferent arteriole, which causes constriction of afferent arteriole </span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:Symbol\">&rarr;</span></span></strong><strong> </strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;So, the blood flow is decreased.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/27/whatsapp-image-2023-06-12-at-1901240.jpg\" style=\"height:477px; width:700px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2. TGF</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The macula densa, a plaque of specialized tubular epithelial cells located in the distal tubule, monitors the NaCl concentration of the tubular fluid and sends an as of yet unidentified signal to control glomerular hemodynamics. In this mechanism, called tubuloglomerular feedback (TGF), an increase in NaCl concentration at the macula densa constricts the glomerular afferent arteriole and thus decreases the single-nephron GFR. Along with the myogenic response, TGF significantly contributes to renal autoregulation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. NO</span></strong><span style=\"font-size:12.0pt\">: Incorrect, as nitric oxide generally causes vasodilation, not the contraction associated with the myogenic response.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Noradrenaline</span></strong><span style=\"font-size:12.0pt\">: Incorrect, although noradrenaline can affect blood vessel tone, it is not directly involved in the myogenic response mechanism of renal autoregulation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Adenosine</span></strong><span style=\"font-size:12.0pt\">: Incorrect, adenosine is more involved in tubuloglomerular feedback rather than the myogenic mechanism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In renal autoregulation, the myogenic hypothesis states that the afferent arterioles contract in response to increased blood pressure, which stretches the arteriole walls. This contraction is mediated by the opening of calcium channels, leading to an influx of calcium ions and subsequent constriction of the arteriole, thereby helping to stabilize GFR across varying blood pressures.</span></span></span></p>",
    "correct_choice_id": 35065,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  }
];
        let quizName = 'Late Night Pyq:Pyt (Mixed Bag-1)';
        const quizFilename = 'late-night-pyq-pyt-mixed-bag-1-5d03ae44.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on answer selection
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>